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ABSTRACT
The specific activities of phosphofructokinase, aldolase, and 
pyruvate kinase were diminished in crude extracts from skeletal 
muscle of streptozotocin diabetic rats, whereas the activities of 
glucosephosphate isomerase and phosphoglucomutase were not changed.
The decreased phosphofructokinase activity was shown to be 
independent of allosteric control, and it could be reversed by insulin 
treatment. A rapid and mild method for the purification of phospho­
fructokinase from rat skeletal muscle was developed. The partially 
purified enzyme from muscle of normal and streptozotocin diabetic 
rats showed identical Michaelis constants for ATP and equal 
sensitivity to inhibition by excess of ATP. Extracts of quick- 
frozen muscle from diabetic rats had higher levels of citrate, and 
lower levels of fructose 1,6-bisphosphate and glucose 1,6-bisphosphate. 
The levels of fructose 6-phosphate, glucose 6-phosphate, ATP, ADP, 
and AMP were the same for the two groups. These data suggest that 
phosphofructokinase activity is decreased in muscle of diabetic animals 
due to (a) a decrease in extractable activity, when assayed under 
optimum conditions, and (b) an unfavorable change in the levels of some 
of its allosteric modulators.
A precise and reproducible gas chromatographic procedure for 
the determination of anomeric composition of glucose in biological 
fluids was developed. When applied to blood, peaks of the silylated 
glucose anomers were well resolved and were the only two major
xii
peaks found in blood. Blood glucose of normal and alloxan-diabetic 
rats, fed or fasted, was found statistically to have an anomeric 
composition slightly favoring the 3 anomer over the thermodynamic 
equilibrium composition in water (39.1 + 0.6% a- and 60.9 + 0.6%
3-). The anomeric composition of glucose in plasma as well as in 
whole blood remained close to equilibrium after the administration 
of insulin to normal or diabetic rats. However, there was a 
statistically noticeable decrease in the percentage of blood 
3-glucose as a result of insulin treatment of normal animals.
A spin echo nuclear magnetic resonance technique for the non- 
invasive measurement of glycolytic activity in red blood cells from 
normal and diabetic rats was used. No differences were seen between 
the two groups. Proton magnetic resonance spectra of serum from 
normal and diabetic rats were also similar.
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CHAPTER I. COMPARISON OF PHOSPHOFRUCTOKINASE ACTIVITY IN MUSCLE 
OF NORMAL AND DIABETIC RATS
1
INTRODUCTION
Although the effect of experimental diabetes on liver phospho­
fructokinase (PFK) (ATP:3-D-fructose 6-phosphate 1-phosphotransferase,
E.C. 2.7.1.11) has been studied by many groups, possible changes in 
the muscle enzyme have attracted much less attention. Abnormalities 
in the control of PFK have been implicated in various organs of 
diabetic animals (see below) as well as in other diseases (e.g. 
muscular dystrophy (l) and tumor cells (2)). The major means of 
control of PFK activity are reviewed here, as are the known effects 
of diabetes on PFK. Some effects of glucagon are also discussed.
The PFK reaction is the first step unique to glycolysis, and has 
been shown to be the rate limiting step in the glycolytic pathway (3). 
PFK catalyzes the phosphorylation of fructose 6-phosphate at the 
expense of ATP in an irreversible reaction, and produces fructose 1,6- 
bisphosphate. PFK has been shown to be highly specific for 3-fructose 
6-phosphate (4-7), and is strongly regulated by various metabolites 
(4,5,8).
PFK was first discovered in red blood cells in 1935 (9), and in 
muscle in 1936 (10). Seven years after its discovery, Cori (11) 
suggested that PFK was the rate limiting step in glycolysis. Since 
then, PFK has been shown to be responsible, at least in part, for the 
Pasteur effect (12), and for the oscillations in the levels of 
pyridine nucleotides in cells exhibiting glycolytic activity (13).
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Mechanisms for controlling PFK activity have been the subject 
of many investigations. PFK's activity has been shown to be "affected 
by allosteric means, association-dissociation, and possibly, by 
covalent modification, as well as by variations in the concentration 
of enzyme.
Control of PFK:
By allosterism. The velocity of the PFK reaction is known to 
increase in a hyperbolic fashion with increasing substrate concentra­
tion (ATP or fructose 6-phosphate) when measured at pH 8.0 (4). At 
physiological pH, however, PFK shows complex kinetic behavior, in 
that the enzyme velocity increases in a sigmoidal manner with 
increasing fructose 6-phosphate concentration. PFK was first shown, in 
1956, to be inhibited by high levels of its substrate, ATP, when 
measured at physiological pH (14). This inhibition could be overcome 
by increasing the concentration of fructose 6-phosphate, or by the 
addition of AMP, cyclic AMP, ADP, glucose 1,6-bisphosphate, fructose 1,6- 
bisphosphate or ammonium ions (15-19). PFK was found to be inhibited 
by phosphoenolpyruvate, phosphocreatine, 3-phosphoglycerate, 2-phos- 
phoglycerate, and 2,3-bisphosphoglycerate (20), citrate (21), cyclic 
GMP (22), and by low pH (6.9) (23).
For the purposes of this report, conditions under which PFK has 
been shown to exhibit complex kinetic behavior have been termed 
"allosteric conditions", and conditions under which PFK behaves 
according to Michaelis-Menten kinetics are "non-allosteric conditions".
It has been suggested that allosteric regulation of PFK involves 
two tetrameric forms of PFK which are in rapid equilibrium, and differ
by their degree of protonation (24,25). Using intrinsic protein 
fluorescence and binding measurements, Pettigrew and Frieden (25) 
showed that positive effectors (those which reverse ATP inhibition of 
PFK) bind the deprotonated, or active, form of PFK, Whereas 
negative effectors bind, and thus stabilize, the protonated (inactive) 
form. Rro forms of rabbit muscle PFK were also seen by Mathias and 
Kemp (26), based on the reactivity of one specific thiol group. 
Positive effectors of PFK increased-the reactivity of the thiol group, 
and ATP decreased this reactivity. Jones et al. (27) showed two 
conformations of rabbit muscle PFK by monitoring spin-labeled PFK by 
ESR. The spin label, covalently bound to sulfhydryl groups of PFK, 
was decreased in mobility when ATP was bound to PFK, suggesting that 
the spin label was becoming more buried as PFK was undergoing a 
conformational change.
By association-dissociation. ATP was shown to stabilize PFK 
activity at low pH (6.7) (28). However, in the absence of ATP, PFK 
underwent a slow inactivation, as determined by residual PFK activity 
(non-allosteric conditions). Lad et al. (29) correlated rabbit muscle 
PFK activity with the aggregation state of the enzyme, and showed 
that fructose 6-phosphate and fructose 1,6-bisphosphate (activators of 
PFK) stabilized a tetrameric form of PFK, whereas citrate (inhibitor 
of PFK) stabilized a dimer form. In contrast to citrate, ATP (PFK 
inhibitor) did not depolymerize PFK. The tetrameric form of rabbit 
muscle PFK could also be stabilized by high pH (8.0) (30), with 
dissociation occurring at physiological pH, or at low protein concen­
tration ( < 0.2 mg/ml), as determined by frontal gel chromatography. 
Polymerization effects similar to those for muscle enzyme have been
demonstrated for PFK from liver (31).
By covalent modification. In contrast to the well known cyclic 
AMP dependent phosphorylation of phosphorylase b (E.C. 2.4.1.1) and 
pyruvate kinase (E.C. 2.7.1.40)* PFK has not been shown to undergo a 
reversible covalent modification with an accompanying activation- 
deactivation of the enzyme. However* Kagimoto and Uyeda (32) have 
recently shown a glucagon-mediated phosphorylation of liver PFK which 
resulted in increased sensitivity to ATP inhibition under allosteric 
conditions. In 1975, Brand and Soling (33) reported an activation- 
deactivation mechanism for liver PFK by phosphorylation-dephosphoryla- 
tion, but these authors later withdrew their claims that the phosphor­
ylation affected enzyme activity (34). Hofer and Furst (35) 
demonstrated an Jji vivo phosphorylation of skeletal muscle PFK* but 
did not show any change in PFK activity. These demonstrations of 
phosphorylation of PFK suggest a possible covalent modification of PFK 
in vivo; however whether or not this modification of PFK plays an 
important role in the regulation of PFK activity is presently unknown.
Effect of diabetes on PFK:
From muscle. Little work has been done to describe the effects of 
diabetes on PFK from any specific type of muscle; however data are 
available to suggest that there should be a decrease in PFK activity 
in several muscle types (heart* skeletal* diaphragm) in diabetic 
animals. In 1961* Newsholme and Randle (36) reported a decreased ratio 
of fructose 1,6-bisphosphate/fructose 6-phosphate in perfused hearts 
from alloxan diabetic rats* indicating decreased PFK activity.
Newsholme and Randle later showed that perfusion of normal rat hearts 
with fatty acids or ketone bodies also depressed PFK activity (37)*
and suggested that the increased levels of fatty acids and ketone 
bodies which occurred in diabetes inhibited PFK by allosteric means. 
Inhibition of PFK was not a direct effect of the increased levels of 
fatty acids and ketone bodies, but was due to a concurrent 
increase in the level of citrate, as shown by Parmeggiani and 
Bowman (38). Citrate, a PFK inhibitor, was increased in concentration 
in hearts perfused with fatty acids or ketone bodies, and in hearts 
from diabetic animals » and their treatment with insulin 
reduced the levels of citrate. Physiological levels of citrate, but 
not of fatty acids or ketone bodies, were shown to inhibit PFK in vitro 
and therefore, it was suggested that the depressed PFK activity in 
hearts of diabetic rats was due to increased catabolism of lipids 
(resulting in increased levels of citrate) in the diabetic animal (38).
The effect of diabetes on PFK in heart muscle was further studied 
by Regen et al. (39), who confirmed decreased PFK activity in perfused 
hearts of diabetic rats. By measurement of the levels of fructose 6- 
phosphate, fructose 1,6-bisphosphate, nucleotides, and inorganic phos­
phate, they showed that PFK inhibition in the perfused heart of diabetic
rats could be overcome by anoxia. Diabetes did not affect the levels 
of ATP, ADP, AMP, or inorganic phosphate in heart muscle, but anoxia 
resulted in decreased ATP (PFK inhibitor) and increased levels of 
AMP, ADP, and inorganic phosphate (PFK activators). Thus, anoxia 
could reverse the inhibition of PFK in perfused hearts from diabetic 
rats by allosteric means.
Using a radioimmunoassay technique, Hansen and Veneziale (40) 
measured the concentration of PFK in extracts prepared from the left 
ventricle of rabbit heart and from skeletal (antibial) muscle from
normal and alloxan diabetic rabbits. These authors detected no 
differences In the concentration or activity of muscle PFK, and 
suggested that the control at the PFK step was due to allosteric 
effects, rather than to insulin mediated changes in the intracellular 
enzyme.
On the other hand, Ianuzzo and Armstrong (41) showed a decrease 
in the specific activity of PFK in extracts prepared from skeletal 
muscle of streptozotocin diabetic rats. Specific activity of PFK was 
decreased in muscle extracts from diabetic animals, when prepared 
from three different fiber types: slow twitch, oxidative (soleus
muscle), fast twitch, oxidative, glycolytic (axial gastrocnemius), and 
fast twitch, glycolytic (peripheral gastrocnemius). The cause of the 
decreased PFK activity was not investigated.
PFK was the rate limiting step in the metabolism of glucose in 
perfused frog muscle when glycogenolysis was stimulated by epinephrine 
(42), in that glycogen was broken down to hexose monophosphates, but 
little lactate was produced. When insulin was added to the perfusion 
medium, however, the levels of hexose monophosphates decreased, and 
lactate was produced, indicating a stimulation of PFK activity by 
insulin.
Taunton et al. (43) also showed a rapid effect of insulin on 
skeletal muscle PFK. In experiments where rats were injected (intra­
venous) with insulin In situ, then the muscle was excised and the PFK 
was extracted, the specific activity of PFK was increased (assayed under 
under allosteric conditions, pH 7.4). This effect of insulin was 
maximal at 5-10 min following insulin treatment, suggesting a short 
term, insulin mediated effect on muscle PFK.
Beitner et al. (44) demonstrated an Insulin-mediated effect on
PFK activity in rat hemidiaphragm, and showed that this effect was
independent of glucose transport. Hemidiaphragms were preloaded 
14with C-glucose, then incubated in a glucose-free medium with or
without Insulin. Using fast-freezing techniques, these authors
demonstrated increased levels of fructose 1,6-bisphosphate in diaphragms
which had been incubated with insulin, indicating increased PFK
activity. In another experiment, diaphragms were incubated with or
without insulin, and the levels of glucose in the medium were adjusted
so that the rate of glucose uptake was less in the insulin-treated
diaphragms. These experiments showed increased Incorporation of
14radioactivity from G-glucose into carbon dioxide and triglyceride 
glycerol for the insulin-treated diaphragms, indicating increased 
metabolism of glucose, independent of glucose transport.
From liver. Taunton et al. (45) showed rapid (within 4 min) 
increases in liver PFK activity in response to insulin. When rats 
were injected (intravenously) with insulin in situ, then the livers 
excised and the enzymes extracted, activity of PFK and of pyruvate 
kinase was increased, whereas activity of fructose bisphosphatase (E.C. 
3.1.3.11) was decreased. On the other hand, glucagon decreased the 
activities of PFK and pyruvate kinase, and increased fructose bis­
phosphatase activity. Later studies showed these effects to be 
independent of de novo synthesis, as treatment with Actinomycin D or 
puromycin had no effect on the results of these experiments (43).
In addition to the short term effects demonstrated by Taunton 
et al.> a long term effect of insulin on PFK from liver was demonstrated 
by Weber and Singhal (46). PFK activity in liver could be increased
by insulin treatment, and this increase in activity could be blocked by 
actinomycin or ethionine. The mechanism of this effect was studied 
by Dunaway and Weber (47), who reported a decrease in the concentration 
of the major isozyme of PFK in the liver of diabetic rats. Using a 
double isotope technique and an immunoassay for the major (I^) 
isozyme of PFK in liver, these authors showed an increase in the rate 
of degradation of the PFK isozyme in the liver of streptozotocin or 
alloxan diabetic rats. Insulin treatment, on the other hand, resulted 
in increased synthesis and decreased degradation of the isozyme 
of PFK. Dunaway and Segal (48) later discovered that the levels of 
the L2 PFK isozyme were controlled, in part, by a PFK protective 
factor. The level of this factor was decreased in the liver of 
diabetic rats, and could be increased by insulin treatment. Thus, the 
half life for the Lg isozyme of PFK in liver was decreased from 1.8 
days, for normal rats, to 0.6 days, for diabetic rats, due to 
decreased levels of the protective factor (49). The protective factor 
was determined to be a polypeptide of 3500 daltons, consisting of 
equimolar glutamate, glycine, and half-cystine (50). In addition to 
its protective effects on purified liver PFK, the factor was shown to 
activate PFK by facilitating binding of fructose 6-phosphate.
Hosey et al. (51) also studied the major PFK isozyme (I^) in the 
livers of normal and genetically diabetic mice, and showed increased 
sensitivity to ATP for the enzyme from diabetic animals. The diabetic 
animals were hyperglucagonemic, and these authors attributed the 
increased ATP sensitivity to a glucagon-dependent regulation of PFK.
From lens. The activity of PFK was decreased in the lens of the 
alloxan diabetic rat, as evidenced by a decrease in the fructose 1,6-
bisphosphate/fructose 6-phosphate ratio (52). The resulting decreased 
glycolytic flux was responsible for decreased production of ATP in 
lens, according to the authors. Levels of AMP, cyclic AMP, and ADP 
were unchanged in the lens of the diabetic rat.
From renal cortex and epididymal fat. Insulin treatment of renal 
cortex or epididymal fat in situ resulted in increased PFK activity in 
the rat (43). After insulin treatment, the organ was excised, and the 
PFK was extracted and assayed. The effects of insulin were maximal in 
5-10 min, suggesting a mechanism other than de novo synthesis of PFK.
From 3T3 cells. Addition of insulin to quiescent cultures of 3T3 
cells enhanced PFK activity in homogenates prepared from the cells (53) 
This increased PFK activity occurred in the cells with or without 
concurrent treatment with cycloheximide, indicating that de novo 
synthesis of PFK was not involved. Since the increased activity 
persisted whether the enzyme was assayed under allosteric (pH 7.4) or 
non-allosterlc conditions (pH 8.2), the authors suggested that an 
activation of preexisting inactive PFK was responsible for the insulin 
effect.
Effect of glucagon on PFK. Recently, several effects of glucagon 
have been demonstrated for regulation of liver PFK. Although these 
effects have not been implicated in the altered regulation of PFK in 
diabetic animals, they are important in regard to diabetes because of: 
a) the known antagonistic effects of insulin and glucagon, and b) 
the abnormally high ratio of glucagon/insulin in the serum of diabetic 
animals.
Treatment of perfused liver with glucagon resulted in the 
decreased production of a low molecular weight activator of PFK (54-57)
This activator, isolated from liver cells and identified as 
fructose 2,6-bisphosphate, could stimulate PFK at extremely low 
concentrations (0.1 pM) (54). It was suggested, therefore that 
decreased PFK activity in glucagon-treated liver cells was due to 
decreased amounts of this activator. The presence of this activator 
has not been demonstrated in muscle, as yet.
Increased phosphorylation of liver PFK in glucagon-treated 
perfused liver has been demonstrated by Kagimoto and Uyeda (32). The 
phosphorylated PFK had decreased inhibition constants for ATP and 
citrate, resulting in increased sensitivity to inhibition by these 
effectors. Furuya and Uyeda (58) also demonstrated a phosphorylation 
of PFK> concurrent with increased ATP sensitivity, and showed that 
the increased ATP inhibition was not due directly to the phosphor­
ylation of PFK, but to a decreased affinity of phosphorylated PFK for 
an activation factor (59). The activation factor was purified, and' 
shown to be carbohydrate in nature.
Purpose of this investigation. The above mentioned studies 
indicate that PFK activity is decreased in the diabetic state. Studies 
on skeletal muscle PFK have not been conclusive, however, in that 
Hansen and Veneziale (40) found no difference in the concentration or 
activity of PFK in the muscle of diabetic animals, whereas Ianuzzo and 
Armstrong (41) showed decreased PFK activity. In addition, the mech­
anism^) of decreased PFK acitivity in skeletal muscle have not been 
investigated. Therefore, the purpose of this study was to:
1. Determine whether or not PFK activity was decreased in the 
skeletal muscle of diabetic animals; and
2. If PFK activity was found to be decreased, investigate the
nature of the altered PFK activity.
Rats were used In this investigation because of the large number 
of animals needed for each experiment for statistical analysis of the 
data. Little work has been done on rat muscle PFK, and therefore, this 
report includes experiments which probe the properties of rat muscle 
PFK at various stages of purification.
METHODS
Assay of PFK activity. Activity of PFK was measured by coupling 
the PFK reaction to either a ADP system, or to a fructose 1,6-bis- 
phosphate system. For the ADP-coupled system, assay mixtures contained 
0.04 M buffer (tris chloride, pH 7.8, or imidazole chloride, pH 7.2)
4.0 mM magnesium chloride, 0.02 mM EDTA, 1.0 mM dithiothreitol,
2.0 mM phosphoenolpyruvate, 0.16 mM NADH, 0.5 mM ATP, one unit of each 
of pyruvate kinase (E.C. 2.7.1.40) and lactate dehydrogenase (E.C. 
1.1.1.27), and 1.0 mM fructose 6-phosphate. The fructose 1,6-bisphos- 
phate-coupled assay was according to the method of Ling et al. (60), and 
consisted of 0.05 M buffer (tris chloride, pH 7.8, or imidazole chloride 
(pH 6.7 or 7.2), 0.05 M potassium chloride, 5.0 mM magnesium sulfate,
1.0 mM dithiothreitol, 0.16 mM NADH, 0.5 mM ATP, 0.1 unit of aldolase 
(E.C. 4.1.2.13), 0.6 unit of glycerol 3-phosphate dehydrogenase (E.C. 
1.1.1.8), 6 units of triose phosphate isomerase (E.C. 5.3.1.1), and
1.0 mM fructose 6-phosphate. Assays contained 1 to 4 munits of PFK 
activity, and were initiated by the addition of fructose 6-phosphate.
The change in absorbance at 340 nm was measured using a Gilford 
model 250 spectrophotometer, and recorded on a Gilford model 6051 
recorder. One unit of activity was defined as the amount of enzyme 
that would catalyze the production of 1.0 nmole of fructose 1,6-bis- 
phosphate per min at 28°C.
Preparation of crude muscle extract. Rats were killed by decapi­
tation, and muscle from the back and hind legs was excised and placed
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In Ice. Crude extracts were prepared by a modification of the method 
of Ling et al. (61): muscle (5 - 10 g, or 100 g if PFK was to be
purified) was homogenized for 1 min with 3 volumes of 0.03 M potassium 
fluoride, 1.0 mM EDTA at 0 - 4°C, then centrifuged in a Sorvall RC2-B 
centrifuge (SS-34 rotor) for 1 hr at 1300 x g, followed by centrifu­
gation at 10,000 x g at 0 - 4°C. In experiments where PFK activity 
was measured at timed intervals following preparation of the crude 
extract, centrifugation was in an Eppendorf model 5412 centrifuge for 
10 min at 13,000 x g and 0 - 4°C. In these experiments, other buffers 
were substituted for the potassium fluoride, EDTA buffer, as indicated.
Partial purification of rat muscle PFK.
Preparation of the resuspended 104,000 x g pellet. Crude muscle 
extract (156 ml) was centrifuged for 2 hr at 104,000 x g in a Beckman 
L5-75 centrifuge (Ti-75 rotor) at 0 - 4°C. The pellet, containing 
the PFK activity> was resuspended using a teflon tissue homogenizer, 
in 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol 
(other buffers were used in some experiments, as indicated).
Reactive Blue 2-Agarose chromatography. The resuspended 104,000 
x g pellet was dialyzed overnight against 2 x 500 ml of 0.1 M tris 
phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol. The dialyzed 
sample was diluted with one volume of dialysis buffer, then applied to 
a 1.5 x 18 cm column bed of Reactive Blue 2-Agarose (Sigma), previously 
equilibrated with 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA. The 
column was washed with 160 ml of equilibrating buffer, then the PFK 
activity was eluted using a non-linear gradient, constructed from 125 
ml of equilibrating buffer in a 150 ml beaker, and 125 ml of equili­
brating buffer, 1.25 M in ammonium sulfate, in a 125 ml Erlenmeyer
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flask, and connected to the beaker by a salt bridge. Active fractions 
were pooled (65 ml), and concentrated to 15 ml by ultrafiltratlon 
(Amlcon, PM-10 membrane). Partially purified PFK, prepared in this 
manner, was stable for many weeks.
Activation of PFK by MgATP. Crude or partially purified PFK was 
incubated with 1 volume of 0.05 M tris chloride containing 0.01 M ATP 
and 0.01 M magnesium chloride, pH 7.8. PFK activity was measured 
after 20 min of incubation at 28°C. These conditions allow 
for the complete activation of PFK, as determined earlier (62).
Protein determination. Protein was measured by the method of 
Lowry et al. (63), using 0.1 per cent lysozyme (Boehringer) as a 
standard.
Sodium dodecyl sulfate gel electrophoresis. Polyacrylamide gels 
were prepared as described by Weber and Osborn (64) for sodium dodecyl 
sulfate-tris gels, 7.5 per cent in polyacrylamide. Samples containing 
30 - 80 yg of protein, 5 per cent in glycerol, and containing brom- 
phenol blue as a tracker dye, were layered under the reservoir buffer. 
After running at 5 - 8 ma per gel (approximately 8 hrs), gels were 
stained overnight in Coumassie blue.
Induction of diabetes in animals. Sprague-Dawley rats were made 
diabetic by the injection of streptozotocin (Sigma, 65 mg per kg of body 
weight) into the tail vein at least one week prior to use. All 
diabetic rats used in this study had blood glucose in excess of 200 mg 
per 100 ml.
Blood glucose determination. Restrained rats were warmed for a 
few min with a heating mantle, then 1 cm of the tail was excised. 
Heparinized blood samples (20 pi) were measured into 100 yl of
distilled water, and were made protein free by a modification of 
the method of Somolygi (65) as follows: 40 yl of 0.1 N barium
hydroxide was added to each sample with mixing. After 5 min, 40 yl 
of 1.7 per cent zinc sulfate heptahydrate was added with mixing, and 
after 5 min, the samples were centrifuged. Glucose was measured 
according to the method of Okuda et al. (66), using 0.1 per cent 
glucose as a standard.
Assay of enzymes other than PFK. All auxilliary enzymes used 
in these experiments were purchased from Sigma. Crude muscle extracts 
and auxilliary enzymes were dialyzed exhaustively before use (0.1 M 
tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol), and 
enzyme activities were measured at 28°C. The following methods were 
used for the assay of enzymes: phosphoglucomutase (E.C. 2.7.5.1),
Najjar (67); glucosephosphate isomerase (E.C. 5.3.1.9), Noltman (68); 
pyruvate kinase (E.C. 2.7.1.40), Bucher and Pfleiderer (69); and 
fructose bisphosphatase (E.C. 3.1.3.11), Pontremoli (70). Aldolase 
(E.C. 4.1.2.13) assays consisted of 0.04 M imidazole chloride, pH 7.5,
1.0 mM dithiothreitol, 0.16 mM NADH, 0.1 unit of glycerol 3-phosphate 
dehydrogenase, and 1.0 unit of triose phosphate isomerase. The 
reaction, containing approximately 0.01 unit of aldolase activity, was 
begun by the addition of fructose 1,6-bisphosphate (1.0 mM, final 
concentration). Phosphorylase (E.C. 2.4.1.1) was measured by the 
production of glucose 1-phosphate from glycogen. Assay mixtures 
contained 0.16 M potassium phosphate, pH 6.8, 13.2 mM magnesium 
chloride, 1.0 mM AMP, 0.16 mM NADP+ , 0.8 per cent glycogen (Sigma),
4.0 yM glucose 1,6-bisphosphate, 3 units of each of phosphoglucomutase 
and glucose 6-phosphate dehydrogenase (E.C. 1.1.1.49), and a sample
containing approximately 0*01 unit of phosphorylase b. The reaction 
was started by the addition of the sample. Assays without glycogen 
or without phosphorylase served as controls.
For the measurement of the pH optimum of aldolase, reactions 
contained 0.05 M buffer (tris chloride or imidazole chloride, variable 
pH), 0.05 M potassium chloride, 5.0 mM magnesium sulfate, 1.0 mM 
dithiothreitol, 0.16 M NADH, and auxilliary enzymes (0.1 unit of 
glycerol 3-phosphate dehydrogenase and 1.0 unit of triose phosphate 
isomerase). The reaction was started by the addition of 1.0 mM 
fructose 1,6-bisphosphate (final concentration). To determine the 
pH optimum of pyruvate kinase, assay mixtures consisted of 0.05 M 
buffer (tris chloride or imidazole chloride, variable pH), 0.05 M 
potassium chloride, 4.0 mM magnesium chloride, 0.02 mM EDTA, 1.0 mM 
dithiothreitol, 2.0 mM phosphoenolpyruvate, 0.16 mM NADH, and 0.1 
unit of lactate dehydrogenase. The reaction was started by the 
addition of 0.5 mM ADP (final concentration). Lactate dehydrogenase 
assays contained 0.05 M buffer (tris chloride or imidazole chloride, 
variable pH), 0.16 mM NADH, 0.05 M potassium chloride, 4.0 mM 
magnesium chloride, 0.02 mM EDTA, 1.0 mM dithiothreitol, approximately 
0.01 unit of lactate dehydrogenase (Sigma), and 1.0 mM pyruvate 
(added to start the reaction). For measurement of the pH optimum of 
glycerol 3-phosphate dehydrogenase, assays contained 0.05 M buffer 
(tris chloride or imidazole chloride, variable pH), 0.05 M potassium 
chloride, 5.0 mM magnesium sulfate, 1.0 mM dithiothreitol, 0.16 mM 
NADH, 2.0 units of aldolase, 0.1 unit of triose phosphate isomerase, 
approximately 0.01 unit of glycerol 3-phosphate dehydrogenase (Sigma), 
and 1.0 mM fructose 1,6-bisphosphate (final concentration, added to
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8tart the reaction.
Preparation of flash-frozen muscle samples. Rats were 
anesthetized with ether, and the skin was dlsected away from the leg 
and back area. Muscle samples (1 - 6 g) were quickly excised (In less 
than 7 sec) and frozen In liquid nitrogen. The frozen samples were 
pulverized using a stainless steel mortar and pestle in dry ice, 
and stored at -70°C until use. Extracts were prepared from the quick- 
frozen muscle samples by a modification of the method of Lowry et al. 
(71), as follows: the samples were quickly weighed into a cold (dry
ice) 50 ml polyethylene centrifuge tube in the cold room, then 9.0 ml 
of ice cold 3.0 M perchloric acid was added with mixing. After 10 min, 
30 ml of ice cold 1.25 M EDTA was added with mixing (10 min), after 
which the samples were centrifuged at 10,000 x g for 20 min at 0 - 4°C. 
The supematents were poured into 9.0 ml of ice cold 3.0 M sodium 
carbonate. Samples were centrifuged again at 10,000 x g for 20 min, 
and the supematents were stored at -20°C until use.
Assay of metabolites in flash-frozen muscle. Measurement of 
glucose 6-phosphate, fructose 6-phosphate, fructose 1,6-bisphosphate, 
ATP, ADP, and AMP were from the fluorimetric methods of Lowry et al. 
(71). An eppendorf photometer, equipped with a fluorescence attachment, 
was used in these determinations, with a 313 - 366 nm excitation 
filter and a 380 - 3000 nm secondary filter. All enzymes used in 
these measurements were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2 
mM EDTA, 5.0 mM 2-mercaptoethanol) prior to use. Fluorescence grade 
imidazole was purchased from Sigma.
Assay of glucose 1,6-bisphosphate was from the phosphoglucomutase 
velocity method described by Passonneau e£ al. (72). Assay mixtures
contained 0.04 M imidazole chloride, pH 7.4, 2.0 mM magnesium chloride, 
0.2 mM EDTA, 0.04 mM NADP , 1.6 units of glucose 6-phosphate dehydro­
genase, 0.01 unit of phosphoglucomutase, and 5-10 yl of muscle extract 
(adjusted to pH 7.4). The reaction was started by the addition of 
0.015 mM glucose 1-phosphate (final concentration), and the phospho­
glucomutase velocity was recorded spectrophotometrically (340 nm).
A standard curve was constructed, using 30 - 200 yl of 0.2 yM 
glucose 1,6-bisphosphate.
Citrate was measured by the method of Stem (73), with muscle
extract samples representing 1.0 to 1.5 g of muscle.
31P nuclear magnetic resonance spectroscopy. Extracts prepared 
from quick frozen muscle from normal or diabetic rats were pooled, 
passed through a Chelex 100 (Bio-rad) cation exchange column (sodium 
counter ion), and concentrated to 10 per cent of the original volume 
(measured pH of both samples was 10.0). Nuclear magnetic resonance
spectroscopy was on a Bruker WP 200 spectometer, operating at 80.8
megahertz, with broadband proton decoupling. Chemical shifts were 
reported relative to external phosphoric acid.
RESULTS
Kinetic analysis of PFK in crude muscle extracts. Crude 
muscle extracts were desalted by passage through Sephadex G-25, 
previously equilibrated with 0.1 M potassium phosphate, pH 8.0, 1.0 
-mM EDTA, 5.0 mM 2-mercaptoethanol, and were used within 3 hrs of 
desalting. Fig. 1 shows that, at a fructose 6-phosphate concentration 
of 0.5 mM, PFK velocity was maximal at an ATP concentration of 0.5 mM 
(pH 7.8 or 6.7). No ATP inhibition was apparent at pH 7.8, but crude 
muscle PFK showed sensitivity to ATP inhibition at pH 6.7. Rough 
estimates of the Michaelis constants for ATP could be obtained from 
double reciprocal plots of the data, giving a Km of 0.14 mM at pH 7.8, 
and 0.31 mM at pH 6.7. Crude muscle extract showed hyperbolic 
behavior with increasing fructose 6-phosphate concentration at pH 7.8, 
and sigmoidal behavior at pH 6.7 (Fig. 2). When ATP concentration 
was 0.5 mM, PFK velocity was maximal at 1.0 mM fructose 6-phosphate 
(pH 7.8 or 6.7), indicating the enzyme assay described under METHODS 
was measuring PFK activity at maximal velocity in crude muscle extracts. 
Michaelis constants for fructose 6-phosphate were calculated to be 0.13 
mM (pH 7.8, from a double reciprocal plot of the data), and 0.7 mM 
(pH 6.7, from the substrate concentration when velocity is half the 
maximal velocity ).
Effect of extraction buffer on the stability of PFK in crude 
muscle extracts. Fig. 3 shows the activity of PFK in crude extracts 
from rat muscle, prepared using various buffer systems. In three of
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FIG. 1. Velocity of PFK in desalted crude muscle extract at 
varying concentrations of ATP. The fructose 1,6-bisphosphate-coupled 
assay was used in these determinations, and the fructose 6-phosphate 
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FIG. 2. Velocity of PFK in desalted crude muscle extract at varying 
concentrations of fructose 6-phosphate. The fructose 1,6-bisphosphate 
coupled assay was used in these determinations, and the ATP 















FIG. 3. Stability of muscle PFK in crude extracts when extracts 
were prepared with the following buffer systems: (o) 0.03 M
potassium fluoride, 1.0 mM EDTA; (x) 0.1 M potassium phosphate, pH 7.8, 
0.1 M ammonium sulfate, 0.5 mM magnesium chloride, 5.0 mM 2-mercapto- 
ethanol; (•) 0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride, 
0.1 mM EDTA; (■) 0.02 M tris chloride, pH 7.5, 0.12 M potassium 
chloride, 0.1 mM EDTA, 0.5 mM magnesium chloride; (A) 0.25 M sucrose. 
Hie activity of PFK in the crude muscle extracts was assayed by the 
ADP-coupled method at pH 7.8, as described in METHODS.
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the five buffer systems tested (0.1 M potassium phosphate, pH 7.8,
0.1 M ammonium sulfate, 0.5 mM-magnesium chloride, 5.0 mM 2-mercapto­
ethanol; 0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1 
mM EDTA; and 0.2 M tris chloride, pH 7.5, 0.12 M potassium chloride, 
0.1 mM EDTA, 0.5 mM magnesium sulfate), PFK activity was rapidly lost 
after preparation of the extract. On the other hand, activity of 
extracts prepared with 0.03 M potassium fluoride, 1.0 mM EDTA retained 
more than 95 per cent of the original PFK activity. By extrapolation 
of the PFK activity to time = 0 hr, four of the five preparations had 
similar activities at the beginning of the assay period. The fifth 
preparation (prepared with 0.25 M sucrose) had little PFK activity 
throughout the experiment. The activity of PFK which was lost in 
three of the crude muscle extracts could be restored by activation 
with MgATP, as described in METHODS (Fig. 4).
The measured pH of the crude extracts in Fig. 3 was 6.4 to 6.7, 
indicating that PFK in the potassium fluoride, EDTA system was stabil­
ized by some factor other than pH. In another experiment, however, 
stability of PFK was dependent on the pH of the muscle homogenate 
(Fig. 5). When the pH of the crude muscle homogenate was adjusted to 
8.7, PFK in the resulting muscle extract was stable (pH of the extract 
was 7.8 after 5 hrs of storage, and the extraction buffer was 0.02 M 
tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1 mM EDTA). If 
the muscle homogenate was adjusted to pH 7.9 or 7.0, however, PFK 
activity was rapidly lost (resulting crude extracts were pH 6.8 and 
pH 6.5 after 5 hrs of storage, respectively). The activity of PFK 
could be restored by activation with 5.0 mM MgATP (Fig. 6).
Effect of dialysis on PFK activity in crude muscle extracts.
FIG. 4. Activity of muscle PFK in crude extracts when prepared 
with various buffer systems, then activated with 5.0 mM MgATP before 

















FIG. 5. Stability of PFK in crude muscle extracts of varying pH. 
Hie extraction buffer was 0.02 M tris chloride, pH 7.5, 0.12 M 
potassium chloride, 0.1 mM EDTA, and the pH of the homogenates were 
adjusted prior to centrifugation. The measured pH of the extracts 
were (o) 6.5, (x) 6 .8, and (•) 7.8 after 5 hrs of storage.
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FIG. 6. Activity of PFK in crude extracts of varing pH when 
activated with 5.0 mM MgATP before assay. The extraction buffer was 
0.02 M tris chloride, pH 7.5, 0.12 M potassium chloride, 0.1 mM EDTA, 
and the pH of the extracts prior to the activation step were (o) 6.5, 




Muscle extracts, prepared with 0.03 M potassium fluoride, 1.0 mM EDTA, 
were dialyzed against various buffer systems. Table I shows a loss 
of PFK activity with every buffer system tested. Potassium fluoride 
(30 mM) did not prevent Inactivation of PFK during dialysis. Magnesium 
chloride at a concentration of 0.5 mM appeared to stabilize the PFK 
activity somewhat, but a higher concentration (5.0 mM) resulted In loss 
of PFK activity. The product of the PFK reaction, fructose 1,6- 
bisphosphate, did not prevent inactivation of PFK, nor did the 
substrate, ATP (5.0 mM). The buffer system providing the greatest 
stabilizing effect for dialysis of crude muscle extracts contained 
0.1 M potassium phosphate, pH 8.0, 0.1 M ammonium sulfate, 0.5 mM 
magnesium chloride, and 5.0 mM 2-mercaptoethanol.
Effect of dilution buffer on PFK activity in crude muscle 
extracts. Crude muscle extracts were prepared, using 0.03 M potassium 
fluoride, 1.0 mM EDTA, and diluted 1:9 (v/v) with various buffer 
systems. After 4 hrs of incubation at 0 - 4°C, the diluted crude 
extracts were tested at pH 7.8 for PFK activity. Fig. 7 shows 
retention of activity (more than 90 per cent) when the dilution buffer 
was 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA. Dilution with the 
extraction buffer (0.03 M potassium fluoride, 1.0 mM EDTA) resulted in 
a loss of 25 per cent of the PFK activity, and if the extraction 
buffer was 5.0 mM in ATP, more than 50 per cent of the activity was 
lost. The other buffers tested (0.2 M imidazole chloride, pH 6.7; 
imidazole chloride, pH 7.3; and tris chloride, pH 7.8) and water, 
resulted in approximately 25 per cent loss of PFK activity.
In another experiment, various dilutions of crude muscle extract 
were made with 0.03 M potassium fluoride, 1.0 mM EDTA. Fig. 8 shows
TABLE I
LOSS OF PFK ACTIVITY IN CRUDE MUSCLE EXTRACT 
BY DIALYSIS IN VARIOUS BUFFER SYSTEMS
Treatment Per cent PFK activity
None 100
Dialysis against 0.1 M potassium phosphate, pH 8.0 12
+ 5.0 mM 2-mercaptoethanol 9
+ 4.0 mM magnesium chloride 0
+ 30 mM potassium fluoride 9
+ 0.2 mM fructose 1,6-bisphosphate 6
+ 0.2 mM EDTA 9
Dialysis against 0.1 M potassium phosphate, pH 8.0,
5.0 mM 2-mercaptoethanol, 0.1 M ammonium sulfate,
0.5 mM magnesium chloride 74
- 0.5 mM magnesium chloride 57
- 0.1 M ammonium sulfate 65
+ 4.5 mM magnesium chloride 28
Dialysis against 0.1 M tris phosphate, pH 8.0,
0.2 mM EDTA, 5.0 mM ATP 41
FIG. 7. Activity of PFK in crude muscle extracts when diluted 1:9 
(v/v) in various buffer systems, and incubated at 0 - 4°C for 4 hrs. 
The results are expressed relative to extract which was diluted 
with 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA just before assay, 
and are the average of two experiments.
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a b c d e f g
a. 0 .0 3 M KF, I.OfflM EDTA (pH 5.3)
b. "a" with 5.0 mM ATP (pH 5.3)
c. 0.1 M tris -P 04l pH 8.0, 0.2 mM EDTA
d. 0.2 M imidazole Cl, pH 6.7
e. 0.2 M imidazole-CI, pH 7.3
f. 0.2 M tris-CI, pH 7.8
g. water
FIG. 8. Specific activity of PFK in crude muscle extract when 
diluted with extraction buffer and incubated at 0 - 4°C for 5 hrs. 
















that a slight dilution (8:2, crude extractrbuffer) resulted in 
increased PFK activity. Further dilutions of crude muscle extract 
did not affect PFK activity until crude extract represented only 40 
per cent of the volume, after which PFK activity was lost with dilution.
Effect of desalting and dilution of PFK activity in crude muscle 
extracts. Crude muscle extract was desalted by passage through a
1.5 x 30 cm Sephadex G-25 column which had been previously equilibrated 
with 0.1 M potassium phosphate, pH 8.0, 1.0 mM EDTA, 5.0 mM 2-rmercapto- 
ethanol. The protein fractions were pooled and diluted (1:0, 1:1, 1:4, 
and .1:9, v/v) with buffer (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA,
5.0 mM 2-mercaptoethanol, 0.1 per cent bovine serum albumen). Fig. 9 
shows a rapid loss of activity when PFK was diluted 1:9 with buffer.
Loss of activity was slower at lower dilutions, but activity was lost 
in all samples tested.
In other experiments, where little dilution of PFK occurred in 
the desalting step, little or no PFK activity was lost for 3 hrs (data 
not shown). Therefore, further experiments using desalted crude 
extract were done with care to avoid dilution of the crude extract 
during the desalting step, and desalted extracts were used within 3 
hrs without further dilution.
Stability of the resuspended 104,000 x g pellet. PFK activity of 
the 104,000 x g pellet was rapidly lost when it was resuspended in
0.03 M potassium fluoride, 0.2 mM EDTA, but activity could be recovered 
by treatment of the resuspended pellet with 5.0 mM MgATP (Fig. 10).
PFK activity could be retained if the resuspending buffer contained
5.0 mM ATP (see Table II), or if the pellet was resuspended in 0.1 M 
tris phosphate, pH 8.0, with or without 5.0 mM ATP. When the
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FIG. 9. Effect of dilution on stability of PFK activity in desalted 
crude muscle extract. Desalting was done on a 1.5 x 30 cm Sephadex 
G-25 column which had been previously equilibrated with 0.1 M potassium 
phosphate, pH 8.0, 1.0 mM EDTA, 5.0 mM 2-mercaptoethanol at 0 - 4°C.
The protein fractions were pooled and diluted with 0.1 M tris 
phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 2-mercaptoethanol, 0.1 per cent 
bovine serum albumen as follows: (o) no dilution, (x) 1:1 (v/v),
(•) 1:4, and (□) 1:9. Diluted samples were tested for activity, 
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FIG. 10. PFK activity of the 104,000 x g pellet when resuspended 
in 0.03 M potassium fluoride, 1.0 mM EDTA. Samples were assayed 







STABILITY OF PFK ACTIVITY IN RESUSPENDED 104,000 X G PELLET 
IN VARIOUS BUFFER SYSTEMS WITH OR WITHOUT MgATP ACTIVATION
Resuspension buffer* Activation PFK**
1. 0.03 M potassium fluoride, 1.0 mM EDTA, 5.0 no 50
mM 2-mercaptoethanol (pH 5.7) yes 100
2. No. 1, but with 0.1 per cent bovine no 15
serum albumen (pH 5.5)
3. No. 1, but with 5.0 mM MgATP (pH 6.1) no 100
4. No. 1, but with pH adjustment to 8.5 no 5
(pH 7.5 after 10 hrs) yes 5
5. No. 1, but with 1.0 mM fructose 6-phosphate (pH 6.0) no 50
6. No. 1, but with 0.5 mM MgATP (pH 6.1) no 50
7. Original supematent (pH 6.3) no 100
8. Original supematent, made protein free by no 50
ultrafiltration (pH 6.3)
9. 0.2 M imidazole chloride, pH 7.3, 5.0 mM ATP no 100
10. 0.2 M tris phosphate, pH 8.0, 5.0 nM ATP no 100
11. 0.2 M tris phosphate, pH 8.0 no 100
* pH of resuspended pellet is in parentheses
** PFK activity after 24 hrs of incubation at 0 - 4°C is expressed 
relative to activity just after resuspension.
resuspended pellet (in 0.03 M potassium fluoride, 0.2 mM EDTA) was 
adjusted to pH 8.5, activity was lost, and could not be recovered by 
treatment with 5.0 mM ATP. PFK activity was lost when the pellet was 
resuspended in a protein-containing buffer (0.03 M potassium fluoride, 
0.2 mM EDTA, 0.1 per cent bovine serum albumen), as well as when it 
was resuspended in the original supernatent which had been made 
protein free by ultrafiltration (Amicon, PM-10 membrane).
Partial purification of rat muscle PFK. Table III gives a 
summary of the purification procedure, and Fig. 11 shows the chroma­
tography of the resuspended 104,000 x g pellet on Reactive Blue 2- 
Agarose. The centrifugation of the crude muscle extract at 104,000 
x g precipitated most of the PFK, since little activity could be 
detected in the supematent (not shown), and centrifugation for a 
longer period of time, or at higher speeds gave no further recovery 
of activity in the pellet. Chromatography on Reactive Blue 2-Agarose 
resulted in further purification of PFK, since little of the protein 
in the resuspended 104,000 x g pellet adhered to the Reactive Blue 
2-Agarose (Fig. 11). The PFK activity, bound to the Reactive Blue 
resin, was eluted using an ammonium sulfate gradient.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis of the 
purification fractions showed an enrichment of the higher molecular 
weight proteins by the 104,000 x g centrifugation step (Fig. 12). 
Chromatography of the resuspended 104,000 x g pellet on Reactive Blue 
2-Agarose resulted in a preparation which had one major, and two minor, 
bands on polyacrylamide gels. The major band was Identified as PFK, 
by co-migration with rabbit skeletal muscle PFK (Sigma), and the lower 
and higher molecular weight contaminants were identified as pyruvate
TABLE III
PARTIAL PURIFICATION OF RAT SKELETAL MUSCLE PFK
Fraction volume units/ml total units recovery protein total protein specific activity fold
(ml) (per cent) (mg/ml) (mg) units/mg protein purification
Crude extract 156 18.9 2953 100 8.0 1248 2.4 1.0
104,000 x g
pellet 14 113.1 1561 53 18.0 248 6.3 2^6
Reactive Blue
2-Agarose 15 65.5 983 33 1.2 18 54.6 22.8
FIG. 11. Chromatography of the resuspended 104,000 x g pellet on 
Reactive Blue 2-Agarose. The resuspended pellet, containing 0.25 g 
of protein, was applied to a 1.5 x 18 cm column which had been 
previously equilibrated with 0.1 M tris phosphate, pH 8.0, 0.2 mM 
EDTA. The column was washed with 160 ml of buffer, then the PFK 
activity was eluted with a non-linear gradient of ammonium sulfate 





























FIG. 12. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
of PFK purification fractions. Protein (30 - 80 yg) was layered 
under the reservoir buffer, then gels were run at constant current 
(5 - 8 ma per gel). Staining was with Coumassie blue.
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kinase and phosphorylase b, respectively, by co-migration with commercial 
preparations of these enzymes (Sigma). The purified PFK preparation 
had pyruvate kinase activity (6 per cent of the PFK activity) and 
phosphorylase activity (1 per cent).
PFK activity could not be eluted from the Reactive Blue 2-Agarose 
when the eluant was 1.0 mM fructose 1,6-bisphosphate, 0.1 M tris 
phosphate, pH 8.0, 0.2 mM EDTA; or 0.5 M tris phosphate, pH 8.0,
0.2 mM EDTA. PFK activity could be eluted using a 0.0 - 5.0 mM ATP 
gradient, but this procedure increased the contamination of the final 
preparation with phosphorylase b. AMP could also be used to elute 
PFK activity from Reactive Blue 2-Agarose, but afforded no improvement 
over ammonium sulfate.
Other attempts to increase purification of rat muscle PFK.
The following treatments of crude muscle extracts were unsuccessful 
in increasing the specific activity of crude PFK: (a) 50°C
heat treatment for 3 min (extract reached 30°C), followed by rapid 
cooling in ice; (b) adjustment of the extract to pH 5.0 for 30 min
at 0 - 4°C, and (c) addition of isopropanol (25 per cent of muscle
extract volume) at 0°C. After treatment of crude extract as described
above, extracts were centrifuged at 10,000 x g for 30 min and tested
for PFK activity.
In attempts to increase the specific activity of the 104,000 x 
g pellet, the pellet was resuspended in 0.1 M tris phosphate, pH 8.0,
0.2 mM EDTA, 5.0 mM 2-mercaptoethanol; (b) buffer "a" containing 5.0 
mM ATP; or (c) buffer "a" containing 5.0 mM ATP and 8.0 mM citrate, 
and centrifuged at 104,000 x g at 0 - 4°C for 2 hrs. These treatments 
did not increase the purification of rat muscle PFK.
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Following the Reactive Blue 2-Agarose step, chromatography of the 
partially purified PFK on hydroxylapatite eliminated one of the 
contaminating proteins from the partially purified PFK preparation, 
but a loss (greater than 80 per cent) of PFK activity occurred. 
DEAE-cellulose chromatography was also tried, but recoveries and 
specific activities of PFK were less favorable than with Reactive 
Blue 2-Agarose.
pH optimum of rat muscle PFK. The activity of partially purified 
rat muscle PFK was measured at various pH values, using both the ADP- 
coupled, and the fructose 1,6-bisphosphate assay systems, and identical 
curves were obtained for the two assay, systems (Fig. 13). The activity 
of partially purified rat muscle PFK had a broad optimum at pH 7.8 to 
pH 8.2, and PFK activity dropped off at pH values less than 7.5 or 
greater than 8.5. In the construction of the PFK pH curves, the 
amount of auxilliary enzymes used in the assay was increased until 
no further increase in PFK activity was apparent, particularly at pH 
values where the activity of the auxilliary enzymes was low (see 
below).
Since the measured activity of PFK at various pH values was 
dependent, in part, on the activity of the particular auxilliary 
enzymes employed in the assay, the pH curves of the auxilliary enzymes 
were also constructed (Fig. 14 for the ADP-coupled assay enzymes and 
Fig. 15 for the enzymes from the fructose 1,6-bisphosphate-coupled 
system).
Kinetic analysis of partially purified rat muscle PFK. Figs. 16 
and 17 give the ATP and fructose 6-phosphate saturation curves, 
respectively, for partially purified PFK when assayed at pH 7.8. When
FIG. 13. Sensitivity of partially purified PFK to pH, using 
imidazole chloride (o) or tris chloride (x) as buffer. Results 
obtained with the fructose 1,6-bisphosphate coupled- and the ADP- 
coupled assay systems were identical. PFK and auxilliary enzymes 
were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, 5.0 mM 








FIG. 14. Sensitivity of the auxilliary enzymes of the ADP- 
coupled PFK to pH. The enzymes were (A) pyruvate kinase, and (B) 
lactate dehydrogenase, and the buffers were (o) Imidazole chloride 
or (x) tris chloride. All enzymes were dialyzed (0.1 M tris 



















FIG. 15. Sensitivity of the auxilliary enzymes of the fructose
1,6-bisphosphate-coupled assay to pH. The enzymes were (A) fructose 
bisphosphate aldolase, and (B) glycerol 3-phosphate dehydrogenase, and 
the buffers were (o) imidazole chloride or (x) tris chloride. All 
enzymes were dialyzed (0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA,
















FIG. 16. Velocity of partially purified PFK at increasing 
concentrations of ATP and pH 7.8. The Michaelis constant + S.E.M. 
for ATP, determined from these data, was 0.17 + 0.04 mM. The fructose
1,6-bisphosphate-coupled assay was used in these determination, 
and the fructose 6-phosphate concentration was 0.5 mM.
PFK VELOCITY
P o
FIG. 17. Velocity of partially purified PFK at increasing 
concentrations of fructose 6-phosphate (pH 7.8). The Michaelis 
constant + S.E.M. for fructose 6-phosphate, determined from these 
data, was 0.11 + 0.02 mM. The fructose 1,6-bisphosphate-coupled 
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fructose 6-phosphate concentration was 0.5 mM, the Michaelis constant 
for ATP (+ S.E.M.) was 0.17 + 0.04 mM (determined from a regression 
analysis of the double reciprocal plot of the data). The Km for 
fructose 6-phosphate (ATP concentration = 0.5 mM) was 0.11 + 0.02 mM.
At pH 7.2, the partially purified enzyme showed sigmoidal 
behavior to fructose 6-phosphate (Fig. 18), with an apparent Km 
of 0.25 mM (determined by the substrate concentration where enzyme 
velocity was half maximal). A Hill number of 2.4 was calculated for 
the partially purified enzyme, as determined from a plot of In S 
versus In (Vmax-v)/v, where S=substrate concentration, Vmax=maximal 
velocity, and v=velocity. (See below for results on Km for ATP.)
Comparison of PFK activity in crude muscle extracts from normal 
and diabetic animals. Crude muscle extracts were prepared from muscle 
of normal and diabetic rats, and the specific activity was measured 
without prior dialysis of the crude extracts. Table IV shows that the 
specific activity of PFK in extracts from muscle of diabetic animals 
was lower than that from normal animals. The difference in PFK 
activity persisted when tested under conditions which do not subject 
PFK to allosteric control- (pH 7.8, p<0.01 by paired t-test), or which 
allow allosteric control of the enzyme (pH 6.7, p<0.05).
Comparison of specific activities of several enzymes of glucose 
metabolism in muscle extracts from normal and diabetic animals. Crude 
extracts were dialyzed, and measured for specific activity of 
phosphoglucomutase, glucosephosphate isomerase, PFK, fructose bis- 
phosphate aldolase, pyruvate kinase, and fructose bisphosphatase. The 
specific activities of PFK, aldolase, and pyruvate kinase were 
decreased in muscle extracts from diabetic rats (Figs. 19 and 20),
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FIG. 18. Velocity of partially purified PFK at increasing 
concentrations of fructose 6-phosphate (pH 7.2). The Michaelis constant 
was 0.26 mM and the Hill number was 2.4. The ADP-coupled assay was 














SPECIFIC ACTIVITY OF PFK IN CRUDE EXTRACTS PREPARED FROM 
SKELETAL MUSCLE OF NORMAL AND DIABETIC RATS 
Values are means + S.E.M., with the number of pairs of animals in 
parentheses.
Group — PFK Specific activity—  
non-allosteric allosteric 
conditions conditions
Blood glucose Body weight 
(mg/100 ml) (g)
(17) (8)
Normal 2.08 + 0.05 1.18 + 0.12
* ** 





403 + 11 (m) 
245 + 6 (f)
285 + 14 (m) 
205 + 6 (f)
*statistically different, p <0.01 by paired t-test
**statistically different, p <0.05 by paired t-test
FIG. 19. Specific activity + S.E.M. of enzymes in crude extracts 
prepared from muscle of normal and diabetic animals. The enzymes 
were (1) phosphoglucomutase, (2) glucosephosphate isomerase, (3) PFK, 
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FIG. 20. Specific activity + S.E.M. of several enzymes of glucose 
metabolism in dialyzed crude extracts from muscle of diabetic rats, 
expressed as a per cent of the activity from normal animals. The 
enzymes were (1) phosphoglucomutase, (2) glucosephosphate isomerase, 
(3) PFK, (4) fructose bisphosphate aldolase, and (5) pyruvate kinase.
ENZYME
SPECIFIC ACTIVITY (% OF NORMAL)
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whereas specific activities of phosphoglucomutase and glucosepho sphate 
isomerase were equal in crude extracts from the two groups. No 
fructose bisphosphatase activity could be detected in any of the crude 
muscle extracts under the conditions of this experiment (data not 
shown).
Measurement of metabolites In muscle of normal and diabetic rats. 
The levels of fructose 1,6-bisphosphate and glucose 1,6-bisphosphate 
were decreased in extracts prepared from quick-frozen muscle from 
diabetic rats (Table V). On the other hand, the levels of citrate, 
a potent inhibitor of PFK, were elevated in the muscle of diabetic 
animals. The levels of fructose 6-phosphate, glucose 6-phosphate, ATP, 
ADP, and AMP were equal in muscle extracts from the two groups.
nuclear magnetic spectroscopy of extracts from quick-frozen
31muscle from normal and diabetic rats. The P spectra of extracts 
from normal and diabetic rats (spectra not shown) indicated no 
observable differences in phosphorylated metabolites, except in the 
monophosphate ester region (4.7 - 5.3 ppm). The position of the 
resonances which differed between the two spectra coincided with the 
position for fructose 1,6-bisphosphate, as shown by the addition of 
this compound to the extract. The most prominent resonance in each 
spectrum was from creatine phosphate, followed by that of ATP. The 
observed resonances were: 4.7 - 5.3 ppm, sugar phosphates; 3.7 ppm,
inorganic phosphate; 0.0 ppm, phosphoric acid (external reference);
-2.2 ppm, creatine phosphate; -4.3 and -4.5 ppm, y-phosphate of ATP; 
-4.7 and -5.0, 6-phosphate of ADP; -9.3 and -9.6, a-phosphate of ADP; 




LEVELS OF PFK MODULATORS IN MUSCLE
OF NORMAL AND DIABETIC ANIMALS
Values are means + S.E.M., with number of pairs of animals in 
parentheses
— pinole per g of muscle  P value
normal diabetic (paired t-test)
glucose 6-phosphate (7) 1.77 + 0.10 1.84 + 0.33 p > 0.05
glucose 1,6-bisphosphate 0.020 + 0.004 0.007 + 0.002 p < 0.01
(15)
fructose 6-phosphate (7) 0.22 + 0.01 0.24 + 0.04 p > 0.05
fructose 1,6-bisphosphate 0.61 + 0.10 0.31 + 0.04 p < 0.05
(7)
citrate (15) 0.21 + 0.01 0.26 + 0.02 p < 0.05
ATP (15) 4.26 + 0.48 5.59 + 0.16 p > 0.05
ADP (12) 0.46 + 0.04 0.73 + 0.01 p > 0.05
AMP (12) 0.07 + 0.01 0.07 + 0.01 p > 0.05
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Sensitivity of partially purified PFK from normal and diabetic 
rats to inhibition by ATP. Fig. 21 shows identical behavior of 
partially purified PFK from normal and diabetic rats to ATP at pH 7.2. 
The Michaelis constants for ATP (+ S.E.M., calculated from a regression 
analysis of a double reciprocal plot of the enzyme velocities at ATP 
concentrations less than 0.2 mM) were within experimental error 
(0.32 + 0.09.mM for PFK from muscle of normal animals, and 0.41 + 0.13 
mM for PFK from diabetic animals). Fructose 6-phosphate was 0.5 mM in 
these experiments.
Effect of insulin treatment of PFK activity in extracts from 
muscle of diabetic rats. Streptozotocin diabetic rats were given a 
daily injection (intraperitoneal) of 10 units of regular insulin 
(Iletin-40, Eli Lilly) or vehicle (0.8 per cent saline) for 5 days.
Three hrs after the final injection, the rats were sacrificed* and 
extracts of the muscle were prepared as described in METHODS. Table VI 
shows a significant increase in PFK specific activity in crude 
extracts from the insulin-treated rats (2.52 + 0.10 units/mg of protein, 
mean + S.E.M., for insulin-treated animals versus 1.99 + 0.08 units/ 
mg for saline-treated rats).
Insulin treatment of muscle homogenates did not result 
in increased PFK activity. Incubation of homogenates with up to 16 
units of insulin per 10 ml of homogenate followed by centrifugation 
resulted in no change in PFK specific activity in the crude extract 
(Table VII).
FIG. 21. Sensitivity of partially purified PFK from muscle of 
normal and diabetic rats to concentration of ATP (pH 7.2). Data are 
expressed relative to the enzyme activity at pH 7.8, when ATP and 
fructose 6-phosphate concentrations were 0.5 mM and 1.0 mM, 
respectively. The Michaelis constants for ATP for the enzyme from 
normal and diabetic rats (+ S.E.M.) were 0.32 + 0.09 mM and 0.41 + 
0.13 mM, respectively (determined from regression analyses of 
double reciprocal plots of the data at concentration of ATP less 
than 0.2 mM). The ADP-coupled assay was used in these measurements, 














PFK ACTIVITY IN CRUDE MUSCLE EXTRACTS FROM STREPTOZOTOCIN 
DIABETIC RATS WITH OR WITHOUT INSULIN TREATMENT 
PFK activity was measured by the ADP-coupled assay at pH 7.8
Treatment   Mean + S.E.M.------------
PFK specific activity blood glucose 
units/mg protein mg/100 ml
Insulin (8 rats) 2.52+0.10 7 2 + 8
Vehicle (8 rats) 1.99+0.08 4 6 7 + 1 9
* at time of sacrifice
** significantly different by student's t-test at p<0.001
TABLE VII
EFFECT OF IN VITRO INSULIN TREATMENT ON PFK ACTIVITY 
IN HOMOGENATES OF SKELETAL MUSCLE OF DIABETIC RATS
pH of assay units of insulin added PFK Specific activity








*The amount of crude extract used in the assay at pH 6.7 was twice the 
amount used at pH 7.8
DISCUSSION
Before a comparison of PFK activity in skeletal muscle of normal 
and diabetic rats could be made, it was necessary to investigate the 
properties of PFK from skeletal muscle of the rat. Specifically, a 
procedure was needed to stabilize PFK activity in crude extracts of 
muscle, and throughout the purification scheme.
This report shows that PFK in crude muscle extracts could be 
stabilized by a potassium fluoride, EDTA extraction buffer. Potassium 
fluoride did not stabilize PFK directly, since its inclusion in 
dialysis buffer did not stabilize PFK activity (Table I), nor did 
potassium fluoride stabilize the resuspended 104,000 x g pellet (Fig. 
10). EDTA varied in concentration in the various buffer systems, and 
its concentration did not appear to be crucial.
Ling et al. (61) were the first to use potassium fluoride to 
stabilize PFK in muscle extracts. The fluoride anion has been used in 
purification schemes by other laboratories (58,74), but the precise 
mechanism for the stabilization of PFK activity by potassium fluoride 
has not been determined, nor has the means of activation of PFK by 
MgATP.
A possible explanation for the stabilization of PFK by potassium 
fluoride is its glycolysis-inhibiting property. By inhibition of 
glycolysis at the enolase (E.C. 4.2.1.11) step, potassium fluoride 
would slow the catabolism of PFK-stabilizing hexose phosphates. 
Alternatively, potassium fluoride is known to inhibit phosphoprotein
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phosphatase (E.C. 3.1.3.2) (76), and thus could be preserving 
a phosphorylated form of PFK or PFK-actlvatlng component.
Searches for a phosporylation-dephosphorylation control mechanism 
of PFK activity have not been successful, however (34,62,77). Fluoride 
anion is also known to inhibit muscle ATPase (E.C. 3.6.1.3) (78), 
adenylate deaminase (E.C. 3.5.4.6) (79), and adenylate kinase (E.C.
2.7.4.3) (80), and inhibition of these enzymes could affect 
preservation of PFK activity.
Another possible explanation is the activating effect of cyclic 
AMP on PFK, and the known adenylate cyclase (E.C. 4.6.1.1)-activating 
effect of potassium fluoride (81). However, the substrate of adenylate 
cyclase (ATP) is low in concentration in extracts prepared from 
excised muscle (measured as <0.04 mM, data not shown), and therefore, 
production of cyclic AMP may not account for the ability of potassium 
fluoride to stabilize PFK activity over long periods of time (1 week). 
The mechanism for preservation of PFK activity by potassium fluoride, 
therefore, remains elucive.
When potassium fluoride was not included in the extraction buffer, 
PFK activity could be stabilized by high pH (Fig. 5) or by treatment 
with 5.0 mM MgATP (Figs. 4 and 6). The tetrameric (active) form of 
purified rabbit muscle PFK has been shown to be stabilized by high 
pH (8.0), ATP, fructose 6-phosphate, or fructose 1,6-bisphosphate (24, 
28,29). In these experiments, therefore, treatment of muscle extracts 
with high pH, ATP, or potassium fluoride may work by preserving the 
active (tetrameric) form of PFK. The data in Table II are in agreement 
with this explanation, in that the PFK activity in the resuspended 
104,000 x g pellet was stable if the resuspension medium was high pH
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(8.0) phosphate buffer, or if the medium contained 5.0 mM ATP.
Stabilization of PFK activity appeared to be complex, since PFK 
activity was not stable when the 104,000 x g pellet was resuspended 
in potassium fluoride, EDTA buffer, and adjusted to high pH (8.5,
Table II), nor was PFK stable in crude muscle extracts when dialyzed 
against buffer containing hexose phosphate or ATP, or a buffer of 
high pH (8.0, Table I). In addition, PFK activity was not stable 
when crude muscle extract was diluted in buffer containing high 
levels of ATP. These observations suggest that there may be some PFK 
stabilizing factor present in crude muscle extract which is generated 
from ATP and preserved by potassium fluoride.
Moreover, maintainance of PFK activity in crude muscle extracts 
may involve a large molecular weight component, since resuspension of 
the 104,000 x g pellet In its own deproteinated supematent (super- 
natent had been subjected to ultrafiltration to remove high molecular 
weight components) resulted in PFK activity loss (Table II). Resuspen- 
tion of the pellet in its untreated supematent resulted in retention 
of activity, indicating that the loss of PFK activity (above) was not 
due to the high speed centrifugation.
Based on these experiments, the following procedures were used 
for further work: 1) Crude muscle extracts were prepared using 0.03 M
potassium fluoride, 1.0 mM EDTA, as this formula stabilized PFK 
activity in crude muscle extracts, 2) the 104,000 x g pellets were 
resuspended in 0.1 M tris phosphate, pH 8.0, 0.2 mM EDTA, and this buffer 
buffer was used for dilution of crude muscle extracts; 3) desalted 
crude muscle extracts were used within 3 hrs of desalting, as the PFK 
activity was stable in this time period; and 4) dialysis of crude
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muscle extracts was avoided, wherever possible.
In contrast to the many procedures available for purification 
of rabbit muscle PFK (61,74,82), few purification schemes have been 
worked out for rat muscle PFK. Tornheim and Lowenstein (15) reported 
a purification procedure for rat muscle PFK, claiming a 52-fold 
purification (23 fold is reported here) and a 75 per cent recovery 
(33 per cent reported here). However, these authors did not include 
potassium fluoride in their extracting buffer, and in a later step, 
incubated the preparation with 5.0 mM ATP. Their recoveries and yields 
were high, in that these calculations would have been based on 
inactivated PFK in the crude extract, and ATP-reactivated PFK 
in the final preparation. The final preparation was contaminated with 
several enzymes and therefore was not as clean as the PFK preparation 
reported here. The PFK preparation described in this report gave PFK 
which was sufficiently clean to be used for comparison of kinetic 
properties of PFK from normal and diabetic rats.
This investigation revealed a significant decrease in PFK activity 
in the muscle of diabetic rats. This finding is supported by two 
types of experiments: 1) a decrease in PFK activity in extracts
prepared from muscle of diabetic animals (Table IV); and 2) a 
decrease in the fructose 1,6-bisphosphate/fructose 6-phosphate ratio in 
extracts prepared from fast-frozen muscle of diabetic rats (Table V).
The decreased PFK activity in crude muscle extracts from diabetic 
animals could be reversed by insulin treatment (Table VI). Taunton 
et al. (43) also reported increased PFK activity in muscle extracts 
prepared from insulin-treated animals, as did Ozand and Narahara (42). 
These earlier studies suggested a short term effect of insulin, since
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the effects seen by these workers were immediate. In the experiments 
reported here, the decreased PFK activity in the muscle of diabetic 
animals was not due to allosteric control, because PFK activity was 
measured under non-*allosteric, as well as allosteric, conditions.
These results are in agreement with those of Ianuzzo and Armstrong 
(41), but are in contrast to those of Hansen and Veneziale (40).
Possible explanations for decreased PFK activity in diabetic 
rats include a decreased synthesis, or increased degradation of PFK, 
or a covalent (inactivating) modification of PFK. Ah increase in the 
rate of degradation of rat liver PFK from diabetic animals was 
observed by Dunaway et al.) (49), but a similar increase in PFK 
degradation in muscle of diabetic animals has not been demonstrated, 
nor has a decrease in synthesis of PFK. The results in Figs. 19 and 
20 suggest an attractive theory for an insulin-mediated increase in 
glycolytic enzymes. Figs. 19 and 20 show that three enzymes of glucose 
metabolism were decreased in activity in the muscle of diabetic 
animals, and two enzymes were not decreased. The three enzymes which 
were decreased in activity (PFK, aldolase, and pyruvate kinase) were 
unique to glycolysis, whereas the two enzymes which were not decreased 
(phosphoglucomutase and glucosephosphate isomerase) were not unique to 
glycolysis. Insulin may increase the concentration of an 
inducer for the de novo synthesis of the enzymes of glycolysis, 
and thereby mediate the levels of glycolytic enzymes concurrently.
An alternative explanation for the decrease in PFK activity in 
the muscle of diabetic animals is a covalent modification of PFK. If 
a covalent modification was involved in the regulation of PFK in the 
muscle of diabetic animals, an alteration in kinetic behavior might
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be apparent, as was seen for livers of genetically diabetic mice by 
Hosey 6t_al. (51). However, partially purified PFK from muscle of 
normal and diabetic rats showed equal sensitivity to inhibition by 
ATP, and had statistically identical Michaelis constants for ATP 
(Fig. 21). While this kinetic analysis suggests that a covalent 
modification does not explain the decreased PFK activity in the muscle 
of diabetic animals shown in Table IV, a covalent modification of 
PFK cannot be ruled out at this time, since future work may reveal a 
covalent change not detected by the conditions of these experiments.
The levels of allosteric effectors of PFK in vivo could strongly 
affect muscle PFK activity, based on the kinetic analysis of partially 
purified PFK. For example, the Michaelis constant for ATP was 
determined to be 0.3 - 0.4 mM when fructose 6-phosphate was 0.5 mM, 
and the pH was 7.2 (Fig. 21). The measured in vivo concentration 
of fructose 6-phosphate was close to the level used in this kinetic 
analysis (0.2 mM, Table V), and the in vivo concentration of ATP was 
4 - 5  mM. Under these conditions, PFK would be strongly inhibited by 
ATP, and dependent upon the presence of positive effectors of PFK for 
activity.
This report shows decreased levels of two positive effectors of 
PFK in the muscle of diabetic rats, and increased levels of one 
inhibitor. Fructose 1,6-bisphosphate and glucose 1,6-bisphosphate 
(PFK activators) were decreased in concentration in the muscle of 
diabetic animals. Decreased levels of fructose 1,6-bisphosphate were 
also observed for heart muscle (36,37,39) from diabetic rats. A 
comparison of the levels of glucose 1,6-bisphosphate in muscle of normal 
and diabetic animals has not been previously reported. Muscle of
diabetic rats had increased levels of citrate (PFK inhibitor), in
agreement with the results of Parmeggiani and Bowman (38). Increased
levels of citrate have also been demonstrated in the heart and liver
of diabetic animals (38). ATP, ADP, and AMP are known effectors of
PFK, but no differences in the levels of these three modulators
were found in the muscle of normal and diabetic animals, in agreement
with the results of Regen et̂  al. (39) and Newsholme and Randle (37) for
heart muscle. No unexpected phosphorylated metabolites were detected
31in the muscle of diabetic animals by P nuclear magnetic resonance 
spectroscopy, in contrast to the findings of Burt et al. (83) for 
dystrophic muscle.
This investigation has shown decreased activity of PFK in muscle 
of diabetic rats, due to 1) a decrease in the extractable activity of 
PFK, reversible by insulin treatment; and 2) an unfavorable change 
in allosteric modulators of PFK. Moreover, the levels of glucose 
6-phosphate and fructose 6-phosphate were equal in the muscle of normal 
and diabetic rats (Table V), indicating glucose transport was not 
limiting in the metabolism of glucose in muscle, thus emphasizing the 
importance of this work.
CHAPTER II. GAS CHROMATOGRAPHIC PROCEDURE FOR THE ANALYSIS OF GLUCOSE 
ANOMERS IN THE BLOOD OF NORMAL AND DIABETIC RATS
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INTRODUCTION
Glucose exists in at least two anomeric forms, and consequently 
glucose receptors and glucose transport systems have been found that 
are specific for either the a or the 6 anomer of glucose. The
relative concentrations of glucose anomers in the blood, as well as 
the total glucose concentration, could affect rates of 
glucose utilization. Enzymes using glucose as substrate have not 
shown specificity for either anomer of glucose; however, enzymes 
using glucose 6-phosphate as substrate show anomeric specificity, and 
therefore the relative concentrations of a and 3 glucose could affect 
enzymatic rates indirectly.
Mutarotase (E.C. 5.1.3.3, aldose 1-epimerase) is an enzyme 
which catalyzes the equilibration of glucose anomers, and is high 
in activity in liver, kidney, and intestine. Transport processes and 
enzymes which preferentially utilize one glucose anomer over the 
other could tend to enrich the blood in one anomer, whereas mutarotase 







Effect of g and B glucose on insulin and glucagon secretion. 
Insulin is secreted by the pancreas in response to a rise in glucose 
concentration in the blood. Recently, it has been determined that 
the a anomer of glucose is the actual secregogue responsible for the 
insulin response. Rossini et al. (84) infused a or 8 glucose into 
live, anesthetized rats which had been fasted for 24 hr, and found 
that more insulin was secreted into the blood when a-glucose was the 
anomer used. Similarly, more insulin was secreted by perfused rat 
pancreas when a-, rather than 8-glucose was included in the perfusion 
medium (84). The specificity of the pancreas for the a anomer was 
most pronounced after 1 min of infusion, probably due to the rapid 
mutarotation of glucose at physiological temperature during longer 
infusion periods. Niki et al. (85) also demonstrated that more 
insulin was secreted from rat pancreas when perfused with the a-, 
rather than the 8"» anomer of glucose, and Idahl et al. (86) showed 
that more insulin was released when a-glucose was perfused through 
islets from mice.
McDaniel et al. (87) isolated rat islets by the collagenase 
technique, and perfused them with solutions containing a- or 8-glucose. 
More insulin was released from the islets when the a anomer was used, 
at a concentration of 150 mg per 100 ml. At higher concentrations, 
the differences between the results of experiments using a- or 8“ 
glucose were not distinct; however this may have been due to 
spontaneous mutarotation of the glucose anomers. Consistent with the 
effects of glucose anomers on pancreas cells from rats and mice,
Hill (88) demonstrated that when fasted dogs were infused intravenously 
with a or 8 glucose, more insulin was released into the blood when
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a-glucose was the anomer used.
Glucagon is a hormone whose effects are generally antagonistic 
to those of Insulin. Glucagon Is secreted by the a cells of the 
pancreas, and its secretion is inhibited by serum glucose. Rossini 
et al. (84) reported more inhibition of glucagon secretion when a- 
glucose, versus 6-glucose or equilibrated glucose, was perfused 
through rat pancreas. Grodsky et al. (89) also showed increased 
insulin, and decreased glucagon secretion when a-glucose was perfused 
through rat pancreas. Thus, the specific effect of a-glucose was 
shown to be the stimulation of the secretion of insulin, and the 
inhibition of the secretion of glucagon.
Newton eit al. (90) compared the sensitivity to a- and 8-glucose 
of pancreatic islets from lean mice to the sensitivity of islets 
from their genetically obese litter mates. Islets from lean mice 
showed an expected increase in insulin secretion when perfused with 
a-, rather than 6-glucose. On the other hand, islets from the obese 
mice did not distinguish between glucose anomers, suggesting a defect 
in the specificity of the glucose receptor in islets from the obese 
mice.
The synthesis of proinsulin has been shown to be stimulated 
specifically by the a anomer of glucose (91). Isolated islets from 
rats were perfused with equilibrated glucose for 60 min, then with 
a- or 6-glucose for 3 - 5  min periods, followed by treatment with the 
same anomer of glucose and radioactive leucine (5 min). After 
termination of the experiment with cold leucine, proinsulln and insulin 
were isolated together by immunoprecipitation, and incorporation of 
labeled leucine into newly synthesized insulin and proinsulin
was determined. At glucose concentrations of 100 mg per 100 ml, 
perfusion with the a anomer resulted In more synthesis of (pro)- 
Insulin.
The Insulin secretory response of the pancreas to glucose Is 
accompanied by accumulation of cyclic AMP In the Islets and efflux 
of Inorganic phosphate from the 3 cells, and both of these responses 
were more pronounced when the a anomer of glucose was used to perfuse 
Islet cells (92,93). When Isolated rat Islets were Incubated with a 
phosphodiesterase inhibitor, radioactive ATP, and a- or 3-glucose, 
higher levels of cyclic AMP could be extracted from the islets 
when a glucose was the anomer used (150 mg per 100 ml) (92). In 
another study, isolated islets were prelabeled with radioactive 
inorganic phosphate by a 90 min preincubation at 37°C, then perfused 
with 90 mg per ml of a-glucose or equilibrated glucose. In this 
investigation, more phosphate was recovered from the medium when the 
perfusion buffer contained a-glucose (93).
Treatment of animals with alloxan results in reduced insulin 
secretion due to alloxan induced damage to the 3 cells (94). The a 
anomer of glucose was more effective than was 3-glucose in protecting 
the pancreas from alloxan toxicity (85,87,95). When isolated rat 
islets were perfused with alloxan and with a- or 3-glucose, the islets 
sustained less damage when a-glucose was the anomer used (87). Niki 
et al. (85) also showed better protection against alloxan toxicity in 
isolated rat islets using the a anomer of glucose. The 3 anomer of 
glucose gave more protection than the control (no glucose); however 
this could have been due to mutarotation of the 3-glucose during the 
experiment. Tomita and Kobayashi (95) demonstrated anomer specific
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protection against alloxan toxicity in a similar experimental design, 
also showing better protection of the 3 cells by a-glucose.
Insulin mediated Changes in blood glucose anomers.
Madreiter et al. (96) reported an increase in the relative concentra­
tion of the a anomer of glucose in blood following administration of 
insulin to children. However, a change in the anomeric composition 
of blood glucose could not be demonstrated in normal or diabetic dogs 
when given 0.4 to 0.5 units of insulin (intravenous) per kg of body 
weight (88). In both of these studies, initial glucose concentrations 
were near equilibrium.
Specificity of glucose transport mechanisms for a- or 3-glucose. 
pancreatic islets. When isolated islets were incubated at 37°C
3with labeled (1- H) a- or 3-glucose, more radioactivity disappeared 
from the medium when 3-glucose was the anomer used (97), indicating 
specific uptake of the 3 anomer of glucose. Idahl et al. (86)
3incubated islets with equilibrated (5- H) glucose and unlabeled a-
3or 3-glucose, and showed more dilution of ^ 0  in the cells when 3- 
glucose was the anomer used, supporting preferential uptake and 
metabolism of 3-glucose. More glucose 6-phosphate was found in 
intact islets after perfusion with 3-glucose than when perfused with 
a-glucose (86), and since hexokinase was shown to phosphorylate 
a- and 3-glucose at equal or nearly equal rates (98), this indicated 
faster uptake of the 3 anomer.
In contrast to the above reports of specific transport of 3- 
glucose in pancreatic islets, Idahl et al. (86) reported equal 
counter transport of 3-0-methyl glucose in preloaded islets for 
both glucose anomers. In another experiment, islets were perfused
without glucose, then exposed to 108 mg per 100 ml of a- or B-glucose.
The resulting glucose 6-phosphate in islets was equal in concentration
for both glucose anomers (99). A third experiment showed that equal
3concentrations of were generated from islets perfused with
3a- or (3-glucose (5- H) (98). Whether or not glucose transport is
anomer specific in pancreatic islets is uncertain.
Whereas the studies discussed above showed faster uptake of
the (3 anomer of glucose into pancreatic islets, or no specificity,
Malaisse at al. (100) showed faster metabolism of a-glucose in
pancreatic islets. When intact islets from rats were incubated with
a- or (3-glucose for 5 min, lactate production was facilitated when
the a anomer was used. In another experiment, islets were incubated
14for 5 min with labeled ( C) equilibrated glucose and unlabeled a- or 
B-glucose. The radioactive carbon dioxide was more highly diluted 
when the a anomer was used, supporting a a-glucose specific step 
in either transport or metabolism (100). These data suggest that the 
glucose transport system for pancreatic cells may be specific for 8- 
glucose, or non-specific, whereas the glycolytic pathway may have 
a rate limiting step which is a-glucose specific.
brain. Betz e£ al. (101) demonstrated more inhibition of
3H-glucose transport in canine brain, perfused in situ with a-glucose, 
indicating preferential transport of a-glucose by the blood-brain 
glucose carrier. In cerebral cortex slices, however, a lower Km 
for glucose transport was found for the g anomer (10 mM) than for the 
a anomer (16.3 mM), suggesting faster uptake of B-glucose (102). 
Similarly, in synaptosomes, neurons, and glial cells, uptake of 8- 
glucose was faster than was the uptake of a-glucose. The different
anomeric preferences in these studies may have resulted from multiple 
transport systems in the brain, since glucose must pass the capillary 
vail as well as the plasma membranes of glia and neurons, each of 
which could show different transport properties (103). Okuda (102) 
has suggested that the rate limiting step in vivo may be the higher
Km step (3-glucose specific at the glial cell membrane), with glucose
passing through the glial cell to reach the neuron.
kidney and intestine. Glucose is reabsorbed in the proximal 
tubule of the kidney by an active transport process. Both anomers 
of glucose were shown to be equally absorbed, as determined by a 
study in which glucose anomers were infused into the jugular veins of 
dogs and sampled in the renal veins (104). The small intestine also 
uses active transport as the major mechanism of glucose transport, 
and the rates of absorption of a-, 3-, and equilibrated glucose
were found to be equal (105) .
red blood cells. Glucose enters the erythrocyte by facilitated 
diffusion, and.red cells showed preferential uptake of the 3 anomer 
of glucose (106).
ascites tumor cells. Erlich ascites tumor cells contain an 
active transport mechanism for glucose, and showed preferential 
uptake of the 3 anomer of glucose (107).
retina. Okuda et al. (108) studied uptake of glucose in rat 
retina. When incubated for 3 - 5  min in solutions of a- or 3~glucose
glucose uptake was higher when 3~glucose was the anomer used.
13bacteria. Using (1- C) labeled glucose and nuclear magnetic 
resonance spectroscopy, Ugurbil et al. (109) showed faster 
disappearance from the medium of 3-glucose for Escherichia coli
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cells. In a separate study, Ishihara et al. (110) monitored oxygen 
consumption of germinating spores, and observed that more oxygen 
was consumed when spores were incubated with 0-glucose. The 
preferential utilization of 0-glucose by Bacillus subtilis and 
Bacillus meeaterium spores was explained by the rapid production of 
0-glucose specific dehydrogenase in sporulating cells. Dormant 
spores of JJ. meeaterium germinated when exposed to the 0, but not 
the a anomer of glucose (HI).
yeast. It was shown as early as 1922 that a-glucose was utilized 
faster than 0-glucose in the early stages of fermentation (112), 
suggesting a difference in transport or metabolism for the two anomers.
More recently, Ehwald et al. (113) confirmed this finding for yeast, 
using aerobic and anaerobic conditions. The a anomer was also more 
effective in inhibiting uptake of 2-deoxyglucose. Since 2-deoxy- 
glucose phosphorylation was inhibited equally by a- and 0-glucose, 
the rate limiting step in glucose metabolism by yeast was suggested 
to be a-glucose specific transport into the cell (113).
Anomeric specificity of enzymes which use glucose 6-phosphate 
as substrate.
glucosephosphate isomerase. Isomerization of glucose 6-phosphate 
to fructose 6-phosphate, catalyzed by glucosephosphate isomerase, was 
faster with the a anomer of glucose 6-phosphate, suggesting specificity 
of glucosephosphate isomerase for a-glucose 6-phosphate (99,114). In 
addition, glucosephosphate isomerase was shown to catalyze the 
anomerization of a-glucose 6-phosphate, but not 0-glucose 6-phosphate, 
suggesting specific binding of a-glucose 6-phosphate to the enzyme 
(114)• Schray et al. (115) found that 6-glucose 6-phosphate was also
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used as substrate, but at a slower rate. In the reverse direction, 
a- and 3-glucose 6-phosphates were both products, but the a anomer was 
produced 10 fold faster than was 3-glucose 6-phosphate (116).
glucose 6-phosphate dehydrogenase. The initial enzyme of the 
pentose monophosphate pathway was found to be specific for the 3 
anomer of glucose 6-phosphate (100,114,117) .
phosphoglucomutase. Phosphoglucomutase was shown to be specific 
for a-glucose 6-phosphate, and a-glucose 1-phosphate was the product 
of this reversible reaction (98).
Lack of anomeric spcificity for enzymes which use glucose as 
substrate.
hexokinase. Hexokinase (E.C. 2.7.1.1) has been reported to 
catalyze phosphorylation of both anomers of glucose at similar 
rates, and to have equal, or nearly equal, Michaelis constants for both 
anomers of glucose (98,100,102,107,113,118,119).
glucokinase. Glucokinase (E.C. 2.7.1.2) had no specificity for 
either anomer of glucose, but acted on both anomers at equal rates 
(118)•
mutarotase. Mutarotase catalyzed the anomerization of both 
anomers of glucose, and had equal Michaelis constants for a- and B~ 
glucose (120). The Michaelis constants for both anomers of glucose 
were approximately three orders of magnitude higher than the Km 
values for hexokinase and glucose 6-phosphate dehydrogenase, 
reflecting the high flux of glucose through organs with mutarotase 
activity (121).
Function of mutarotase. The precise function of mutarotase is 
not known, but kinetic constants for mutarotase have been shown to
be similar in magnitude to those for glucose transport (122-127). 
Therefore, a role in glucose transport has been suggested. However, 
Okuda et al. (128) have shown that the cellular location of mutarotase 
is incompatable with a role in glucose transport, in that kidney 
mutarotase was localized in the nucleii of epithelial cells of renal 
tubules and glomeruli, and liver mutarotase was in the nuclei of 
paranchymal cells. In addition, it has been shown that tissues of 
high glycolytic activity are low in mutarotase activity (129,130). The 
actual function of mutarotase may involve the maintainance of glucose 
equilibrium. Although spontaneous mutarotation of glucose at 
physiological temperature was shown to be rapid (t-^ “ min)
(131), infusions of a- or g-glucose into the blood of dogs did not 
reach equilibrium for more than 15 min when the blood was passed 
through a heart-lung machine (ie. the blood was not passed through 
organs of high mutarotase activity). On the other hand, equilibrium 
was reached in the blood of the intact dog within 5 min. This 
investigation suggested a role for mutarotase in the maintainance of 
glucose equilibrium, as did another study which showed the liver 
and kidney to be the most efficient organs for equilibration of 
anomers of blood glucose (104,132).
Anomerization as a rate limiting step in metabolism. It has 
been suggested that mutarotation of glucose 6-phosphate would not 
be a rate limiting step in vivo because of the fast mutarotation 
of glucose 6-phosphate at physiological temperature (t^^ “ 1*5 sec) 
(118). Malaisse (100) showed in vitro, however, that at low glucose 
concentration (11 yM), the rate of appearance of phosphorylated 
fructose was faster with crglucose as substrate than with 6-glucose
76
when glucose 6-phosphate was generated in situ. The possibility 
that anomerization of glucose 6-phosphate Is a rate limiting step 
in vivo remains unresolved.
On the other hand, anomerization of non-phosphorylated glucose 
at physiological temperature was slower (t^/2 ™ m^n) (131), 
and the documentation of glucose anomer-specific transport processes 
suggests that mutarotation of glucose could be rate limiting in vivo. 
Physiological examples have not been demonstrated, however.
Methology used in the study of glucose anomers in biological 
tissues.
polarimetry. The earliest measurement of glucose anomers in 
serum was done in 1925 by Lundsgaard, who utilized polarimetry (133). 
Other analytical methods (below) have superseded polarimetry as 
a means of measuring glucose anomers in biological fluids because of 
the lack of specificity and the low transmission of light through 
fluids of biological origin.
methods involving anomer-specific enzymes. Enzyme assays have 
afforded greater specificity in the study of glucose anomers. 
Bacterial glucose oxidase (E.C. 1.1.3.4), specific for B-glucose, 
has been used in the determination of the relative concentrations
of glucose anomers (134):
B-glucose + 0^ glucose oxidase—  ̂ gluconolactone +
Levels of enzyme were adjusted, such that the rate of anomerization
was slow compared to the oxidation of glucose, and the consumption
of B-glucose could be monitored using an oxygen electrode (85,102,
121,134)» or by using a chromogen and peroxidase (E.C. 1.11.1.7)
(66,88,135,136).
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^2°2 + ĉiromo8en peroxidase color change in response to consumption of
The amount of total glucose was determined from the 3-glucose 
concentration after achievement of equilibrium and the known 
concentration of and 3-glucose at equilibrium. Glucose was 
brought to equilibrium by the use of alkali (88), or by waiting for 
completion of spontaneous mutarotation (24 hrs) (89,91). An 
alternative procedure was to use glucose oxidase £0 measure g-glucose, 
then to add mutarotase to catalyze the anomerization of the remaining 
a-glucose to g-glucose, thereby allowing quantitation of g-, and total 
glucose (66,135).
Another enzymatic procedure utilized hexokinase and glucose 6- 
phosphate dehydrogenase (96). The sample was divided into two parts, 
and one part was treated with glucose oxidase (specific for g-glucose) , 
followed by acid treatment to inactivate the glucose oxidase. The 
concentrations of total glucose (untreated sample) and a-glucose 
(glucose oxidase-treated sample) were then quantitated, using 
hexokinase and glucose 6-phosphate dehydrogenase.
Purpose of this investigation. Because of the evidence for 
anomeric specificity exhibited by glucose receptors, glucose transport 
systems, and glucose 6-phosphate utilizing enzymes, it was of interest 
to compare the anomeric composition of glucose in the blood of animals 
with normal glucose metabolism with that of animals showing abnormal 
glucose metabolism. Hxis report describes a gas chromatographic 
procedure for the accurate and precise determinations of the in vivo 
composition of glucose anomers in blood, and gives data indicating 
that the anomeric composition of glucose in normal and diabetic
rats remains close to the thermodynamic equilibrium in water, whether 
the rats are fed or fasted, and whether they are treated with insulin 
or not. Small, but significant changes in the relative concentrations 
of a- and 3-glucose anomers occurred upon administration of insulin 
to normal rats, and are reported here.
METHODS
Polarlmetric determination of optical purity of Rlucose.
D-glucose (2.5 g of a- (ICN Inc.) or 6- (Pfanstiel Labs Inc.)) was 
weighed into a 50 ml volumetric flask. Water (20°G) was added to 
the mark and the glucose was dissolved by vigorous shaking, after which 
the solution was transferred to a 1 decimeter polarimetric cell 
equipped with a waterbath (20°C). Optical rotation readings were 
taken in a Perkin Elmer 141 (digital readout) polarimeter at timed 
intervals (a ) for 60 min, then again after 24 hr (a ). A plot ofL
In (a - a ) versus time was made, and the initial reading was c
determined by extrapolation. The optical purity was calculated by 
comparison of the t = 0 min values with literature values for 
a-D-glucose (112°) and (J-D-glucose (18.7°) (137).
Derivatization of glucose-containing samples for gas 
c hromatography. A modification of the procedure of Sweeley et_ al.
(138) was used: hexamethyldisilazane (Pierce Chemical Co.) was
mixed with trimethylchlorosilane (Pierce) in a 2/1 ratio (v/v) and 
chilled in ice. To a cold, capped vial containing dry glucose 
(0.02 to 1.0 mg) was added by syringe, 0.2 ml of derivatlzing agent 
and 0.2 ml of dimethylsulfoxide. The mixture was shaken vigorously
for a few min, after which the two phases were allowed to separate, 
and an aliquot of the upper phase, containing the derivatized glucose 
was injected into the gas chromatograph. If an emulsion formed, it 
was broken by refrigeration of the samples. The use of dimethylsulf-
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oxide as solvent rather than the more conventional pyridine served 
to solubilize the dry sugar for derivatization, and to concentrate 
the derivatized sugar in the upper phase. Less tailing occurred in 
the gas chromatographic analysis when dimethylsulfoxide was used 
than with pyridine since little dimethylsulfoxide was contained in 
the injected sample (upper phase).
Gas chromatography of glucose containing samples. Derivatized 
samples (1 - 5 yl of upper layer) were injected onto a 1/8" x 6' column 
(3 per cent SE-30 on Chromsorb W(HP), 80/100 mesh, Pierce) which 
contained a glass sleeve in the injection port. The gas chromatograph 
(Hewlett Packard model 5840, equipped with a microprocessor and flame
ionization detector) was programmed from 165 to 175°C at 0.5°C/min.
The column was reconditioned between runs at 250°C for 5 min. Unless 
otherwise stated, the flow rate (nitrogen) through the column was 
20 ml per min.
Preparation of 1,2,3,4,6-trimethylsily1-glucose. Dry glucose 
(500 mg of a- or 6“» 2.8 mmol) was added slowly to a cold solution 
of 2 ml of pyridine, 1 ml of trimethylchlorosilane, 2 ml of hexa- 
methyldisilazane, and 3 ml of hexane in a 25 ml Erlenmeyer flask, and 
stirred overnight at 3°C. Saturated saline (10 ml) was added, and the 
desired product was extracted with cold hexane (10 ml) three times.
The hexane layers were combined and washed with cold 1 mM hydrochloric 
acid, saturated in saline until the wash layer was acidic by pH paper. 
Hie hexane layers were dried (anhydrous sodium sulfate) and the 
solvent was removed by evaporation under reduced pressure. Ihe 
derivatized a- and 6-glucose samples were mixed in varying ratios, 
then diluted 1/1 (v/v) (carbon tetrachloride) for analysis by
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nuclear magnetic resonance spectroscopy, or 40 mg/25 ml (hexane) for 
gas chromatography.
Induction of experimental diabetes in animals. Sprague-Dawley 
rats (150 - 250 g) were made diabetic by injection into the tail 
vein of 40 - 50 mg alloxan (anhydrous basis) per kg of body weight 
following a 48 hr fasting period, or by injection of 65 mg strepto- 
zotocin (Sigma) per kg. All diabetic rats used in this experiment 
showed non-fasting blood glucose levels greater than 250 mg per 100 
ml of blood.
Collection of blood samples. Blood was collected onto a piece 
of parafilm by snipping 1 cm from the tail of each rat, and 50 yl 
blood aliquots were quickly measured into previously prepared organic 
solvent (below). Usually 3 samples were taken within 30 sec of cutting 
the tail. All samples were taken between 8:00 and 9:30 AM, and were 
cooled in dry ice immediately after collection. For experiments where 
anomeric composition of plasma was measured, the animals were 
sacrificed by decapitation, and several ml of blood was collected 
into a heparinized beaker at 0 - 4°C. After centrifugation in a 
Brinkman tabletop microcentrifuge, model 5412 at 3°C, plasma samples 
were treated as for whole blood.
Preparation of blood samples. Eppendorf centrifuge tubes (1.5 
ml) containing 0.4 ml of chloroform/methanol (10/1, v/v) .and 20 yl 
of 1 mg/ml mannitol in 0.8 per cent saline (internal standard) were 
chilled in a salt/ice bath. Fifty yl of blood was added, after which 
the tube was capped, mixed by vortex mixer, and centrifuged in the 
cold room (3°C) for 1 min. The entire upper layer (methanol) was 
transferred to a prechilled (dry ice/acetone) 3 ml vial, using an
Eppendorf pippette with prechilled (dry ice) tips. After chilling 
in dry ice/acetone, the vials were quickly transferred to prechilled 
(dry ice) flasks, which were then attached to a lyophilization unit. 
The dried samples were capped and derivatized immediately.
Determination of blood glucose.
gas chromatographic procedure. The amount of glucose in blood 
samples was determined using an internal standard (mannitol) by the 
following equasion:
me elucose - (n>e mannitol)(peak area for a- and B-glucose)
(0.826)(peak area for mannitol)
The correction factor for mannitol (0.826) was determined from 10
samples containing known amounts of glucose and mannitol.
enzymatic procedure. Restrained rats were warmed for a few min 
with a heating mantle, then 1 cm of the tail was excised. Heparinized 
blood samples (20 yl) were measured into 100 yl of distilled water, 
and were made protein free by a modification of the method of Somolygi 
(65), as described under METHODS, CHAPTER I. Glucose was measured 
according to the method of Okuda et al. (66), using 0.1 per cent 
glucose as a standard.
RESULTS
Optical purity of glucose samples. Fig. 22 shows the change 
in specific rotation with tine for a sample of each of a- and g-D- 
glucose. Comparison of the extrapolated specific rotation at t ** 0 
min with literature values for a- and g-glucose gave an optical 
purity of 98.5 and 96.6 per cent for the preparations of a- and g-D- 
glucose used in this investigation, respectively (Table VIII).
Gas chromatography. Fig. 23 gives a typical gas chromatographic 
trace of a rat blood sample. The a- and g-glucose peaks were the 
only major peaks obtained in blood. The internal standard, mannitol, 
eluted between the a- and g-glucose peaks, and all 3 peaks were well 
resolved. Samples prepared without the internal standard showed no 
peaks eluting at the same time as derivatized mannitol.
Optimization of gas chromatograph column flow rate. The optimal 
flow rate for the 1/8" x 6 ' SE-30 column was determined using 
derivatized arabinose. Fig. 24 shows the theoretical plate height 
and retention time as a function of flow rate (varied 
from 6.8 to 45.5 ml/min). The theoretical plate height was calculated 
from (139):
Height - 6/(16 ( f  )2) 
where x is the retention volume, and y is the peak volume. A minimum 
height was not achieved, therefore a flow rate of 20 ml/min was used 
in further studies, as this represented a compromise between mln-fmum 
theoretical plate height and retention time.
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FIG. 22. Change In optical rotation of glucose with time. A plot
of In(a - a ) was made, and the value for an was determined by 
u 00 U
extrapolation. Optical purity was determined by comparison of 01q 


























POLARIMETRIC DETERMINATION OF OPTICAL PURITY OF a- AND 8-D-GLUCOSE
































FIG. 23. Gas chromatographic analysis of anomeric composition of 
rat blood glucose. The column (3 per cent SE-30 on Chromsorb W(HP)) 
was programmed from 165 to 175°C at 0.5°C/min. The peaks are as 
follows: a, a-glucose; 11.88 min; b, mannitol (internal standard),












FIG. 24. Change in theoretical plate height with increase 
in column (nitrogen) flow rate. Arabinose (1.6 mg) was derivatized 
as described in METHODS, and 1 yl was injected into the gas 














Optimization of flame ionization detector flow rates. Column 
flow rate (nitrogen) was held constant at 20 ml/min, as hydrogen 
(flame ionization detector) was varied from 6 to 30 ml/min, and air 
was varied from 15 to 30 ml/min. Hie peak area was measured when 
1 yl of derivatized arabinose (1 mg, as described in METHODS) was 
injected onto an isothermal (165°C) column. Figs. 25 and 26 show 
an increase in detector response when the ratio of air to hydrogen 
was increased. From these data, the optimal air and hydrogen flow 
rates were 25 and 15 ml/min, respectively.
Time required for derivatization of glucose containing samples. 
Glucose samples (1 mg) were derivatized and injected into the gas 
chromatograph at timed intervals following derivatization. Fig. 27 
shows the area under the a-glucose curve to reach a maximum at 5 min. 
Five minutes was required for the separation of the two phases so that
an analysis could be made. Completion of the derivatization reaction 
required less than 5 min.
Test for mutarotation of glucose during treatment of samples. 
Glucose (3) was dissolved in ice cold methanol (90 per cent), 
or equilibrated glucose samples were mixed with methanol, and 
treated (sampled, lyophilized, and derivatized) as for blood glucose 
samples. Untreated 3-glucose and lyophilized equilibrated 
glucose samples were derivatized to serve as controls. Table IX 
compares 8-glucose and equilibrated glucose samples which were 
subjected to the "Preparation of blood samples" procedure versus 
their untreated controls. The results indicated no mutarotation 
occurred during treatment of the 8-glucose, or of the equilibrated 
glucose samples.
FIG. 25. Optimization of flame ionization detector response: 
Effect of variation in the ratio of air to hydrogen. One mg of 
D-arabinose was derivatized as described in METHODS, and 1 yl was 
injected into the gas chromatograph for each combination of air and 
hydrogen pressure shown. Air pressure was varied from 15 to 40 
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FIG. 26. Optimization of flame ionization detector response.
The experimental data from Fig. 25 are plotted as a function of air 
and hydrogen pressure (pounds per square inch, psi). The numbers 
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FIG. 27. Determination of time required for derivatization of 
glucose samples. One mg samples of glucose were derivatized as 
described in METHODS, and 1 pi aliquots were injected into the gas 
chromatograph at timed intervals following derivitization, and again 
after 24 hrs. The detector response is plotted as area units at time 













MIN. A FTER  ADDITION OF DERIVATIZING
AGENT
TABLE IX
EFFECT OF BLOOD SAMPLE PREPARATION 
ON ANOMERIC COMPOSITION OF GLUCOSE SAMPLE
Each value Is the average of three determinations.
---------Per cent of anomer---------












* as described in METHODS under ’’Preparation of blood samples”
Lower limit of detection of glucose anomers. Sequential 
dilutions (hexane) were made of the upper layer of a sample containing 
derivatized glucose. Aliquots of 5 yl of each dilution were analyzed 
by gas chromatography. Fig. 28, a plot of the log peak area (a- 
glucose) versus log glucose (mg), shows that the determinations 
were linear over the range of 0.002 - 1.0 mg of glucose. At the 
0.0002 mg level, background noise prevented accurate measurement, 
and therefore the lower limit for analysis of glucose was 0.002 
mg (blood samples routinely contained 0.05 - 0.25 mg of glucose).
Reliability of the eas chromatograph integrator. Table X 
compares the results of several experiments when the results were 
obtained by gas chromatograph integration and by a "cut arid weigh" 
procedure. No significant differences (95 per cent confidence, by 
student’s t-test) were found between the two procedures, indicating 
correct integration by the gas chromatograph integrator.
Comparison of detector response for derivatized a- and 8-glucose 
anomers. Fig. 29 compares the gas chromatographic response for a 
and 8~glucose versus the response obtained by nuclear magnetic 
resonance spectroscopy. A least squares analysis gave a slope of 
1.05, indicating almost identical data obtained by these two 
different techniques and lending credence to the reliability of the 
method described here.
Partitioning of glucose and mannitol into the methanol layer 
during preparation of blood samples. During preparation of blood 
samples, nearly all of the glucose and mannitol was partitioned 
into the upper (methanol) layer (Table XI), in agreement with the 
results of Miwa et al. (121). Extraction of these two sugars was
FIG. 28. Change in gas chromatograph detector response when the 
amount of derivatized glucose injected was varied from 0.002 mg 
(log = -2.7) to 1.0 mg (log = 0).













COMPARISON OF GAS CHROMATOGRAPH RESULTS WHEN QUANTITATED 
BY ELECTRONIC INTEGRATION VERSUS "CUT AND WEIGH"
------------ Per cent anomer + standard deviation -----
Gas chromatograph integration "Cut and weigh"
8 a B
37.70 + 0.56 62.27 + 0.55 37.10 + 0.88 62.90 + 0.88
39.02 + 0.54 60.98 + 0.54 38.85 + 1.18 61.15 + 1.18
37.03 + 0.93 62.97 + 0.93 38.20 + 1.17 61.81 + 1.17
FIG. 29. Correlation of the anomeric composition of glucose sample 
samples determined by gas chromatography with that obtained by 
nuclear magnetic resonance spectroscopy. Derivatized a- and fi-glucose 
were mixed in various ratios, then analyzed by gas chromatography 
(3 to 4 determinations per sample) and by nuclear magnetic resonance 
(3 integrations per spectrum). A least squares analysis of the data 
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PARTITIONING OF GLUCOSE AND MANNITOL INTO THE UPPER PHASE OF THE EXTRACTION MIXTURE
-4Gas chromatograph area units x 10
Sample no. a-glucose (3-glucose mannitol
Upper layer (methanol)
1. 4.39 6.49 0.40
2. 5.28 7.75 2.60
3. 3.40 4.86 1.74
4. 4.04 5.99 2.18
Lower layer (chloroform)
1. 0.01 0.01 0.00
2. 0.00 0.00 0.00
3. 0.01 0.01 0.00
4. 0.00 0.00 0.01
quantitative.
Partitioning of derivatized glucose and mannitol into the upper 
layer of the derivatizing mixture. One yl of the upper layer of 
a derivatized sample, or 10 yl of the lower (dimethylsulfoxide) 
layer was tested by gas chromatographic analysis for the presence of 
derivatized sugar. Neither derivatized glucose or mannitol could 
be detected in the dimethylsulfoxide phase (data not shown), 
indicating complete partitioning of the derivatized sugar into the 
upper layer.
Comparison of anomeric composition of glucose in blood at the 
time of sacrifice and after 24 hrs. The composition of blood glucose 
anomers, when prepared and analyzed immediately after decapitation, 
was equal to the anomeric composition of blood glucose when.the 
blood was held at 23°C for 24 hrs (potassium fluoride was added to 
inhibit glycolysis) (Table XII).
Analytical variability. Aliquots of one rat blood glucose 
sample (extracted, lyophilized, and derivatized as described in 
METHODS) was injected 10 times into the gas chromatograph, and the 
standard deviation of these analyses was calculated. For comparison, 
one analysis of each of 7 derivatized glucose samples (prepared 
from the same rat blood sample) was made, and the standard deviation 
of these data was calculated. Table XIII shows that the variability 
of the determinations among 7 different sample preparations was not 
greater than the instrumental variability observed when one sample 
was repeatedly analyzed, indicating that the precision of the sample 
preparation was equal to or greater than the analytical (gas 
chromatographic) precision.
TABLE XII
ANOMERIC COMPOSITION OF BLOOD GLUCOSE AT
SACRIFICE VERSUS AFTER 24 HR INCUBATION
Time of Per cent of anomer + standard deviation
sample preparation a S
At sacrifice
(10 observations) 36.72 + 0.88 63.28'+_0.88
After 24 hrs
(3 observations) 37.04 + 0.91 62.96 + 0.91
TABLE XIII
COMPARISON OF STANDARD DEVIATIONS OF DETERMINATIONS:
ONE ANALYSIS OF EACH OF SEVEN BLOOD GLUCOSE PREPARATIONS 
VERSUS TEN ANALYSES OF ONE PREPARATION
7 preparations 1 preparation
1 analysis each 10 analyses







Comparison of anomeric composition of blood glucose from
normal and diabetic rats. Table XIV shows the anomeric composition 
of glucose in the blood of diabetic and normal rats to be close to 
equilibrium, but favoring the $ anomer. Normal rats did not 
differ from each other in the fasted or fed states (student's t- 
test), and were not significantly different from diabetic rats. 
However, all groups were significantly different from glucose 
equilibrated in water, and diabetic fed rats were significantly 
higher in the per cent of a anomer than diabetic fasted rats.
When normal or diabetic rats were treated with insulin, blood 
glucose decreased by 54 and 62 per cent, respectively (Table XV). 
The anomeric composition of blood remained close to equilibrium, 
however, the blood of normal insulin-treated rats showed a 
significantly lower per cent of 3-glucose over diabetic insulin- 
treated rats or normal rats without insulin treatment.
TABLE XIV
COMPARISON OF ANOMERIC COMPOSITION OF BLOOD GLUCOSE OF NORMAL AND 
DIABETIC RATS IN THE FASTED AND FED STATES
Group
Normal
fasted (24 hr) 
fed 
Diabetic
fasted (24 hr) 
fed
Per cent + standard deviation 
a-glucose 3-glucose
37.1 + 0.4 
36.8 + 1.0
36.5 + 0.8 
38.0 + 0.5
62.9 + 0.4 
63.2 + 1.0
63.5 + 0.8* 
62.0 + 0.5*
Total glucose 
(mg/100 ml + SD)
83 + 13 
109 + 8
98 + 15 
443 + 69
a. All 4 groups were significantly different from 22 samples of glucose equilibrated in water
(39.1 + 0.6 per cent a- and 10.9 + 0.6 per cent 8-glucose) by student's t-test at the p<0.05
level. The number of rats contained in the normal (fasted, fed) and diabetic (fasted, fed) 
groups was 9, 8, 5, and 6, respectively.
b. Significantly different at p<0.01 level by student's t-test.
TABLE XV
COMPARISON OF ANOMERIC COMPOSITION OF GLUCOSE IN WHOLE BLOOD AND PLASMA FROM 
FED NORMAL AND DIABETIC RATS WITH OR WITHOUT INSULIN TREATMENT
Group Per cent + standard deviation
a-glucose
Normal (9 rats) 
blood 36.9 + 1.0
plasma 37.6 + 0.6
Normal + insulin (4 rats)
blood 39.6 + 0.3
insulin 39.2 + 0.7
Diabetic (6 rats)
blood 38.1 + 0.6
plasma 38.5 + 0.9
Diabetic + insulin (5 rats)
blood 38.0 + 0.3
















(mg/100 ml + SD)
91 + 12 
136 + 15
42 + 13 
60 + 12
460 + 97 
685 + 96
175 + 45 
188 + 61
b,c, p <0.005; d,e, p <0.05 by student's t-test 103
DISCUSSION
The gas chromatographic method of measurement of glucose 
anomers in biological fluids described in this report offers four 
advantages over other procedures: 1) it offers increased accuracy,
since anomerization of the sample cannot occur during analysis;
2) since this procedure is not dependent on the reaction of glucose 
(except for the derivatization), quantitation is not interfered 
with by compounds in biological fluids (eg. ascorbic acid and 
glutathione interfere with procedures using glucose oxidase); 3) 
samples can be prepared, derivatized, and stored for later analysis 
without the possibility of equilibration of the glucose anomers 
during storage, thus facilitating the collection of samples; and 4) 
it can be used for any saccharide which can be derivatized and is 
present in sufficient concentration to be measured (eg. 2 yg per 
sample for the conditions used in this investigation).
The data presented in this report show blood glucose to be 
close to equilibrium for both diabetic and normal rats in t he 
fed and fasted states. This is in contrast to the conclusions of 
Lundsgaard and Hoboll (133), who reported blood glucose of normal 
humans to favor the 0-anomer, whereas blood glucose of diabetics 
was at equilibrium. Miwa et al. (121), using an oxygen electrode 
procedure, also showed blood glucose to be close to equilibrium in 
normal fasted rats, and blood glucose was shown to be close to 
equilibrium in dogs (88).
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Many transport systems have shown a preference for one anomer 
of sugars (86,96,97,99-102,107-110,113), and it was suggested that 
one anomer may be preferentially metabolized in cells (102), thus 
disturbing the equilibrium of blood glucose. Passage of blood through 
organs with high activity of mutarotase, such as liver (136) and 
kidney (129), and the spontaneous mutarotation of glucose (131) tend 
to reestablish the equilibrium. The relative rates of disturbing 
and reestablishing the equilibrium could determine the resulting 
anomeric composition in blood.
Since some transport systems have been shown to be specific 
for one anomer of glucose, insulin-facilitated entry of glucose into 
cells could result in a disturbance of glucose equilibrium in blood. 
Hill (88) showed no change in anomeric composition of blood glucose 
in response to insulin administration, whereas Madreiter e£ al.
(96) reported an increase in the per cent of a-glucose upon 
administration of insulin. The procedure described here is able to 
detect small differences in glucose anomeric composition, and confirms 
a small, but statistically significant decrease in the per cent of 
g-glucose when insulin is administered to normal fed rats.
While the precise metabolic significance of this decrease in 
6-glucose in insulin treated normal rats is unknown, it may reflect 
a preferential uptake of 8-glucose in response to insulin. A similar 
decrease in 6-glucose was not seen in the blood and plasma of 
insulin treated diabetic animals, however the high levels of total 
glucose in diabetic animals may have precluded the observation of 
a change in the relative concentration of glucose anomers.
Further possible explanations for the data in this report
involve a preferential binding of g-glucose by saturable glucose- 
binding component(s) of blood. Glucose equilibrated in water 
contained 39 per cent a- and 61 per cent 3-glucose, whereas glucose 
extracted from the blood of fed or fasted normal rats, or fasted 
diabetic rats favored the 3 anomer (37 per cent a-glucose and 63 per 
cent 3-glucose). This represented the equilibrium composition of 
glucose in the blood of these animals, since incubation of blood at 
room temperature for 24 hrs did not alter the anomeric composition 
of glucose in the blood. The analytical method used in this inves­
tigation did not distinguish between bound and free glucose, and 
therefore would quantitate the total of bound and free glucose.
a-glucose a-glucose -*• 3-glucose 3-glucose
(bound) (free) *■ (free) «- (bound)
A stronger binding of 3-glucose by the glucose binding component(s) 
would shift the above relationship to the right. Thus, an equilibrium 
favoring the 3 anomer of glucose would be apparent. This effect 
would not be as distinct in the blood of the diabetic groups because 
of the high levels of total blood glucose. In fact, the anomeric 
composition of glucose from blood of diabetic animals would be 
expected to approach that of glucose equilibrated in water, as was 
found in this study. The anomeric composition of glucose in plasma 
from normal rats favored the 3 anomer, as did the glucose composition 
in whole blood, and therefore, the saturable glucose binding 
component(s) would be located in the plasma. The existence of these 
glucose binding component(s) has yet to be demonstrated, however.
The data in this report, as in other studies, show a persistence 
in the tendency of blood glucose to be close to equilibrium under
various metabolic conditions. The anomeric specificity of the 
glucose receptors of the pancreas suggests that the regulation of 
blood glucose anomeric composition is important for the maintainance 
of metabolic homeostasis. On the other hand, the demonstration of 
anomer specific transport systems suggests that increased transport 
activity could cause blood glucose to deviate from equilibrium.
These observations suggest that mutarotase may be essential for the 
maintainance of metabolic homeostasis by keeping the a- and $- 
glucose anomers of blood near to, or at equilibrium. This role for 
mutarotase is supported by Hill’s demonstration of a slow equilibration 
of blood glucose anomers when a- or ^-glucose was infused intra­
venously, and blood was not passed through organs of high mutarotase 
activity (88).
CHAPTER III. NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY OF BLOOD CELLS 
AND BLOOD SERUM FROM NORMAL AND DIABETIC RATS
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INTRODUCTION
Glycolytic rates have historically been measured by the 
accumulation of lactate, using methods which require destruction 
of the cell. The technique of nuclear magnetic resonance has found 
value in the field of biochemistry in that it provides a non­
in vasive method of monitoring cellular metabolism. Pertinently,
13 31C and P nuclear magnetic spectroscopy has been used to follow 
the course of metabolic intermediates in living cells (140). Proton 
magnetic resonance of protein containing cells has given 
spectra that are too complex to be useful in the measurement 
of metabolic intermediates. However, the recent development of 
multiple pulse techniques has provided sufficient simplification 
of proton spectra that the in vivo accumulation of metabolic 
intermediates can be detected.
The objective of this study was to use proton magnetic resonance 
to observe the in vivo accumulation of lactate in normal and diabetic 
cells. Red blood cells were used because of their relatively simple 
composition. Glycolytic activity was begun by the addition of 
glucose to cells, however, glycolysis could also be initiated at the 
glyceraldehyde 3-phosphate dehydrogenase (E.C. 1.2.1.12) step with 
the addition of dihydroxyacetone (141). Alternatively, glycolytic 
activity could be terminated by the addition of glycolysis inhibitors, 
and in this manner, the technique described here could aid in the 
characterization of new inhibitors of glycolysis.
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Spin echo techniques for the simplification of protein spectra 
have been studied by Campbell et al_. (142) and Brown et al. (143) .
A 90° - t - 180° - t - FID sequence (where t “ delay time, and 
FID represents collection of the free induction decay data) 
simplifies the spectra of red blood cells because a) the nuclei of 
slow moving components tend to relax in the 2t delay period following 
the 90° pulse; and b) the delay period between the 90° and 180° 
pulses (t) allows nuclei in the inhomogeneous magnetic environment 
outside the blood cells to lose phase with each other (144). Thus 
the spin echo spectrum consists primarily of freely moving 
components located in the interior of the blood cell.
Brindle et al. (144) have taken advantage of the properties of 
spin echo nuclear magnetic resonance to measure membrane transport 
of D- and L-alanine and lactate in the red blood cell, and Brown 
et al. (143) have used spin echo to measure the red cell's internal 
pH. Campbell et al_. (142) simplified the spectra of lysozyme and 
hemoglobin by spin echo techniques, and spin echo has been used to 
demonstrate the mobility of epinephrine in storage vesicles of the 
adrenal gland (145).
This report gives the conditions which have been developed 
for the measurement of in vivo glycolytic rates, using spin echo 
proton magnetic resonance. Experimental results, using blood from 
normal and diabetic rats, show that under the conditions used, no 
differences were seen in the rates of lactate accumulation. Blood 
serum from normal and diabetic rats was also examined, using normal 
proton magnetic resonance. The serum from diabetic rats showed 
higher levels of glucose than did the serum of normal rats, but
other differences were not apparent.
METHODS
Preparation of red blood cells. Heparinized rat blood was 
measured into Eppendorf centrifuge tubes (1.5 ml of blood 
per tube) and centrifuged in an Eppendorf, model 5412 centrifuge 
at 13,000 x g for 2.5 min (0 - 4°C). The serum was removed, and the 
cells were washed with 0.9 per cent saline in D£0 (twice), and with 
Krebs-Ringer buffer (145), pH 7.4, made up in D2O (twice). Just 
before the experiment, cells were centrifuged, warmed to 30°C, and 
resuspended, by vortex, with 100 yl (15 per cent of volume) of 
Krebs Ringer buffer, pH 7.4 ^ O ) ,  with or without 50 mM glucose 
(final concentration, 7.5 mM) . Cells resuspended in this manner 
did not settle during the experiment. Cells were used within 
4 hrs of collection, and the temperature was held at 30°C throughout 
the spectroscopy.
Preparation of rat blood serum. Blood from two rats was pooled 
and centrifuged for 25 min at 9500 x g at room temperature. The 
serum was collected and diluted 1/1 (v/v) with D2O, and lyophilized 
(twice). The dried serum was resuspended in D2O for analysis.
Nuclear magnetic spectroscopy. Measurements were on a Bruker 
WP-200 spectrometer, with chemical shifts relative to external 
3-(trimethylsilyl)propionic acid (sodium). Pulse widths for normal 
spectra were typically 2.5 psec, with a 0.5 sec relaxation delay. 
Data points (2000 - 8000 for normal spectra and 2000 for spin echo) 
were collected over 2000 hertz, with a 0.5 - 2.1 sec aquisition time
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(the shorter times were used for spin echo). Samples were in 
5 mm tubes, with spinning.
Spin echo techniques were from the methods of Campbell et̂  al. 
(142), using a 90° - t - 180° - x - FID pulse sequence. Usually 15 
spectra were taken over a 3 hr period, and stored on a disk. The 
intensity of the lactate methyl peak was normalized to the external 
standard (above). Signal to noise was enhanced by use of an 
exponential multiplier function applied to the free induction decay.
RESULTS
Spin echo experiments. Hie success of the spin echo experiment 
depends, in part, on achieving the correct pulse angle (90°).
The correctness of the experimental parameters was tested by 
observing the lactate methyl resonance (doublet) at various values 
of the delay time, t (Fig. 30). From reference 144 the doublet 
should be inverted when 2t ° 1/J, where J is the coupling constant, 
and should be in phase when t = 1/J. Fig. 30 shows the behavior 
of the lactate methyl resonance to be as predicted, indicating 
correctness of the experimental parameters. (In blood cell 
experiments, the lactate methyl resonance was not a doublet, since 
lactate was produced by the reduction of pyruvate with deuterated 
NADH, and therefore was not inverted, as described above.)
Fig. 31 illustrates the complexity of a normal proton magnetic 
resonance spectrum of rat red blood cells. The spectrum of red 
blood cells was simplified by spin echo, as shown in Fig. 32, 
allowing visualization of the lactate methyl resonance (1.26 ppm). 
This resonance was clearly resolved when a t value of 60 msec was 
used, since only a few resonances were visible in the spin echo 
spectrum. The intensity of the lactate peak increased in a linear 
fashion over the 151 min of the experiment (Fig. 32). The 
accumulation of lactate in red blood cells from normal rats 
was compared with that of cells from diabetic rats (Fig. 33).
No differences in the rates of production of lactate were seen
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FIG. 30. Illustration of change of phase of lactate methyl 
resonance (doublet) with increasing values of t. The values of t 
were a) 0.036 sec; b) 0.072 sec; c) 0.108 sec; and d) 0.144 sec. 
The coupling constant (J) of the doublet was 6.96 hertz (1/J » 






FIG. 31. Proton magnetic resonance spectrum of red blood cells. 
Cells were prepared as described in METHODS, and resuspended in 
Krebs Ringer buffer without glucose. Data points (2000) were 
collected over 2000 hertz (48 scans), with a 0.51 sec aquisition 
time, and a 2.5 ysec pulse width.
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FIG. 32. Spin echo proton magnetic resonance of red blood cells 
at 3 - 151 min after the addition of glucose to washed cells. The 
concentration of glucose was 7.5 mM, and the temperature was held 
constant at 30°C. A 90° - x - 180° - x - FID (90° = 14.5 ysec, 
x = 0.060 sec) pulse sequence was used, with a 0.5 sec relaxation 
delay. Data points (2000) were collected over 2000 hertz, and the 
ratio of signal to noise was enhanced by the use of an exponential 
multiplication function (maximum line broadening of 3 hertz).
The entire spectrum was negated here to display the reference peak 
in an upright position. The actual positions of the lactate and 
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FIG. 33. Increase in concentration of lactate in red blood cells 
from normal and diabetic rats, determined by the non-invasive 
technique of spin echo nuclear magnetic resonance. The intensity 
of the lactate methyl resonance was normalized to the intensity 
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between the two groups in these experiments.
Serum from normal and diabetic animals. Fig. 34 shows the 
normal proton magnetic resonance spectra from normal and 
diabetic animals. Assignments of prominent peaks were made by 
comparison of the spectra with published data on serum lipoproteins 
(147-149). The spectrum of serum from diabetic rats had an 
increased intensity for the resonances in the 3 - 4  ppm region, due 
to serum glucose, but no other major differences between the two 
groups were apparent.
FIG. 34. Proton magnetic resonance spectra of serum from diabetic 
(upper trace), and normal (lower trace) rats. Scans (100) were 
collected, using 8000 data points over 2000 hertz, with a 2.04 sec 











Using spin echo techniques, the lactate methyl resonance was 
clearly resolved. Since few other resonances were apparent, the 
addition of inhibitors of glycolysis would allow the detection 
of specific glycolytic intermediates which would build up due to 
the presence of the inhibitor (provided they do not fall too near, 
or under the signal due to water). liius, this technique could aid 
in the characterization of inhibitors of glycolysis.
No differences were seen in the rates of in vivo accumulation 
of lactate in red blood cells from normal and diabetic rats. 
Differences might be apparent if insulin were added to the cells, 
since many cell types from diabetic animals have increased 
numbers, of insulin receptors (150). Alternatively, cell membranes may 
have been damaged in the cell preparation process.
Blood serum of.streptozotocin diabetic rats is known to be high 
in endogenous and exogenous lipoproteins (151). Although serum 
lipoproteins have been purified and characterized by proton magnetic 
resonance (147-149)* it is difficult to evaluate the serums for 
qualitative differences in the lipoproteins, since many of the lipid 
constituents are common to all lipoprotein classes. Nuclear magnetic 
resonance spectroscopy is able to detect differences in the structure 
of lipoproteins (147-149), since binding of lipids to proteins can 
alter the degree of freedom experienced by the lipid. No differences 
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APPENDIX 
List of abbreviations 
PFK phosphofructokinase 
SD standard deviation
S.E.M. standard error of the mean 
m male 
f female
FID free induction decay 
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